The QualityStocks Daily Tuesday, October 7th, 2025

Today's Top 3 Investment Newsletters

QualityStocks(GLTO) $17.9200 +383.02%

MiningNewsWire(TMQ) $6.5000 +211.00%

MarketClub Analysis(COCH) $1.5900 +97.07%

The QualityStocks Daily Stock List

Galecto (GLTO)

MarketBeat, QualityStocks, MarketClub Analysis, The Online Investor and StreetInsider reported earlier on Galecto (GLTO), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Galecto Inc. (NASDAQ: GLTO) is a clinical-stage biotechnology firm that is focused on the development of molecules that treat inflammation, cancer and fibrosis, among other ailments.

The firm has its headquarters in Copenhagen, Denmark and was incorporated in 2011 by Hans T. Schambye, Tariq Sethi, Hakon Leffler and Ulf Nilsson. It operates in the healthcare sector under the biotech and pharma sub-industry and serves consumers across the globe.

The company builds on over a decade of research focused on the role of lysyl oxidase-like 2 (LOXL-2) and galectin-3 as well as the use of modulators of these proteins in the treatment of cancer and fibrosis-related ailments.

The enterprise’s product pipeline is made up of a selective oral galectin-3 inhibitor known as GB1211 that is undergoing phase 1/2a trials evaluating its effectiveness in treating fibrosis associated with non-alcoholic steatohepatitis and cancer; and a formulation dubbed GB2064 currently in its phase 1/2a trials evaluating its efficacy in treating myelofibrosis, which is a malignant illness of the bone marrow that diminishes its ability to produce blood cells. In addition to this, the enterprise also develops an inhaled galectin-3 inhibitor dubbed GB0139, which is undergoing phase 2 b clinical trials assessing its efficacy in treating serious fibrotic lung ailments, like idiopathic pulmonary fibrosis, which is a fatal progressive fibrotic illness of the lung.

Galecto (GLTO), closed Tuesday's trading session at $17.92, up 383.0189%, on 77,432,222 volume. The average volume for the last 3 months is 22,610 and the stock's 52-week low/high is $2.01/$31.7.

NuCana (NCNA)

QualityStocks, MarketClub Analysis, StockMarketWatch, MarketBeat, TraderPower, 360 Wall Street, Wealth Insider Alert, TradersPro, Schaeffer's, InvestorPlace, FreeRealTime and BUYINS.NET reported earlier on NuCana (NCNA), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

NuCana PLC (NASDAQ: NCNA; FRA: NO4A) is a clinical-stage biotechnology firm which develops new treatments for treating breast, ovarian, pancreatic, biliary, hematology and colorectal cancers, which may better how chemotherapy treatments fight cancer.

The biopharmaceutical firm uses ProTide, its proprietary technology platform to manufacture cancer medications that are better tolerated by patients as well as more effective. This technology was developed by the late Dr. Christopher McGuigan at Cardiff University.

NuCana PLC was founded on January 28, 1997 by Christopher B. Wood and Hugh S. Griffith, who is its current CEO. The firm, which was formerly known as NuCana BioMed Limited, changed its name in August 2017 before launching its IPO shortly after, in September. The company’s IPO generated $115 million. NuCana PLC serves customers in the United States as well as the U.K. and has its headquarters in Edinburgh, United Kingdom.

The company, which has a license agreement, collaboration and research with University College Cardiff Consultants Ltd and Cardiff University, has two primary ProTide technology candidates; NUC-3373 and Acelarin. The firm recently begun clinical trials for these candidates, where the former is in its Phase 1 clinical trial for the treatment of advanced solid tumors while the latter is in different phases of various clinical trials to examine the candidates’ efficacy in treating metastatic pancreatic cancer, biliary cancer, platinum-resistant ovarian cancer and biliary tract cancer. NuCana PLC is also conducting a phase 1 clinical trial for NUC-7738, its candidate designed to treat hematological tumors as well as advanced solid tumors.

NuCana (NCNA), closed Tuesday's trading session at $7.02, up 38.189%, on 2,689,652 volume. The average volume for the last 3 months is 9,787,516 and the stock's 52-week low/high is $2.78/$446.

Bluejay Diagnostics (BJDX)

QualityStocks, Premium Stock Alerts, BioMedWire, The Online Investor, StockEarnings, MarketClub Analysis, Trades Of The Day, MarketBeat and 247 Market News reported earlier on Bluejay Diagnostics (BJDX), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Bluejay Diagnostics Inc. (NASDAQ: BJDX) is an in-vitro diagnostic firm that is focused on the development, manufacture and marketing of minimally invasive POC (point-of-care) diagnostic devices and tests for the inflammation, infectious disease and oncology markets.

The firm has its headquarters in Acton, Massachusetts and was incorporated in 2015. It operates as part of the pharmaceutical and medicine manufacturing industry, under the healthcare sector. The firm serves consumers in the United States.

The company is focused on developing innovative clinical diagnostic products which improve the quality of medical diagnosis. It is party to a research and development agreement with Naval Medical Research Center, which entails the development of a lateral flow rapid test for the diagnosis of different tick-borne ailments, like Lyme disease. The company is also party to a collaboration agreement with Toray Industries Inc. which involves the development of a point of care test for coronavirus patient triage.

The enterprise’s products include a point-of-care device known as the Allereye diagnostic test, which is indicated for the diagnosis of allergic conjunctivitis. It also develops the Symphony biomarker detection platform, which helps detect congestive heart failure, cardiac ischemia, cancer and sepsis. In addition to this, the enterprise offers urine-based HIV-1 confirmatory and screening tests.

Bluejay Diagnostics (BJDX), closed Tuesday's trading session at $2.14, up 38.0645%, on 42,411,721 volume. The average volume for the last 3 months is 6,556,795 and the stock's 52-week low/high is $1.26/$12.45.

Xenetic Biosciences (XBIO)

MarketClub Analysis, StockMarketWatch, QualityStocks, MarketBeat, TraderPower, BUYINS.NET, TradersPro, TopPennyStockMovers, The Online Investor, PCG Advisory, TheMicrocapNews, StockWireNews, Wall Street Mover, PoliticsAndMyPortfolio, Fierce Analyst, Daily Profit and Real Pennies reported earlier on Xenetic Biosciences (XBIO), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Xenetic Biosciences Inc. (NASDAQ: XBIO) (FRA: 3XB) is a biopharmaceutical firm that is focused on developing cell-based therapies that target the B-cell receptor on the surface of malignant tumor cells.

The firm has its headquarters in Framingham, Massachusetts and was incorporated in 2011 on August 9th. It operates as part of the pharmaceutical manufacturing industry, under the health care sector, in the biotech and pharma sub-industry. The firm has eleven companies in its corporate family and serves consumers in the U.S.

The company is party to collaboration agreements with SynBio LLC, PJSC Pharmsynthez, Serum Institute of India Ltd and Takeda Pharmaceutical Co. Ltd. In addition to this, it is also leveraging its proprietary drug delivery platform dubbed PolyXen by entering into partnerships with pharmaceutical and biotechnology companies. The company provides specialist delivery solutions using this platform, which improves the performance and efficacy of vaccines and drugs in various key medical areas, including oncology.

The enterprise’s product pipeline is made up of a personalized CART (chimeric antigen receptor T cell) platform technology dubbed XCART, which has been developed to target patient-specific tumor neoantigens. Additionally, it also develops XBIO-101, an oncology therapeutic investigational drug formulation which is indicated for the treatment of progestin resistant endometrial cancer.

Xenetic Biosciences (XBIO), closed Tuesday's trading session at $4.29, up 32.4401%, on 290,479 volume. The average volume for the last 3 months is 659,125 and the stock's 52-week low/high is $2.2/$5.2683.

Oriental Rise (ORIS)

Premium Stock Alerts and QualityStocks reported earlier on Oriental Rise (ORIS), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Oriental Rise Holdings Limited (NASDAQ: ORIS) is an investment holding firm involved in the planting, cultivation, processing and sale of primarily-processed tea in Mainland China.

The firm has its headquarters in Ningde, China and was incorporated in 2019, on January 25th by Deming Zhou, Wai Kwong Fong and Chun Sun Wong. It operates as part of the packaged foods industry, under the consumer defensive sector. The firm serves consumers across the globe.

Oriental Rise’s business operations are vertically integrated, covering cultivation, processing of tea leaves and the sale of tea products to tea business operators and end-user retail customers. It operates through the Primarily Processed Teas and Refined Teas segments. The Processed Teas segment mainly provides white tea and black tea while the Refined Teas segment mainly provides refined white tea and black tea. The processed tea refers to fresh tea leaves that have been roughly processed by initial steps including picking, wilting, drying and grading. On the other hand, the refined tea refers to processed tea that is subjected to additional processing including sifting, removal of branches and stalks, compressing, drying and packaging. It sells its products to tea business operators and end-user retail customers.

The company recently announced that it had entered into a non-binding letter of intent to acquire 100% equity interests of leading tea distributors in China; Ningde Minji Tea Company Limited and Fujian Daohe Tea Technology Company Limited. This move positions Oriental Rise to become a leading player in China’s tea industry by combining the firm’s capital strength, broader strategic vision, and brand awareness with the target’s heritage in tea culture, regional production footprint, and established distribution network.

Oriental Rise (ORIS), closed Tuesday's trading session at $0.159, off by 5.3571%, on 7,931,151 volume. The average volume for the last 3 months is 95,860 and the stock's 52-week low/high is $0.076/$56.01.

Canaan Inc. (CAN)

CryptoCurrencyWire, BillionDollarClub, CurrencyNewsWire, QualityStocks, MarketClub Analysis, Schaeffer's, StockEarnings, InvestorPlace, MarketBeat, TradersPro, StreetInsider, AllPennyStocks, Stockhouse, Dividend Report, Energy and Capital, INO Market Report, Investment Insights Report, Investors Alley, The Online Investor, Acorn Wealth, Wealth Daily, The Street, SmarTrend Newsletters, Early Bird, Stock Fortune Teller, TopStockAnalysts, StockMarketWatch, BUYINS.NET, Trades Of The Day, StocksEarning and InvestorsUnderground reported earlier on Canaan Inc. (CAN), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Brazil is becoming a new hotspot for cryptocurrency mining, thanks to a growing surplus of clean energy. Over the past years, the country has invested heavily in wind and solar power. Government incentives encouraged rapid growth in renewable energy projects, but the expansion of transmission infrastructure has not kept pace.

As a result, some energy plants now waste up to 70% of the electricity they generate. This surplus has caught the attention of crypto mining companies looking for cheap and abundant power. Cryptocurrency mining requires large amounts of electricity to operate machines that solve complex mathematical problems. In many countries, these operations have put pressure on power grids.

In Brazil, however, crypto mining could actually help balance the energy system. Mining operations are flexible, meaning they can increase or decrease their energy use depending on availability. This makes them ideal consumers for excess renewable energy, especially during times when the grid is under less demand.

Several companies have already started exploring opportunities in Brazil. Renova Energia, for example, plans a $200 million mining project in Bahia. The project includes six data centers that will use power from a local wind farm. Tether, a major digital asset company, is also investing in Brazil. It plans to use renewable energy from sugarcane mills to power its Bitcoin mining operations.

Other firms, including Penguin, Enegix, and Bitmain, are negotiating projects and exploring the northeastern regions of Brazil, which have the largest energy surplus.

Energy providers in Brazil are also interested in these developments. Companies such as Casa dos Ventos, Engie Brazil, and Auren Energia are looking at ways to monetize unused power by working with crypto miners.

Even Eletrobras, the country’s largest electricity provider, is running a pilot project using ASIC mining machines combined with solar panels, wind turbines, and battery storage. These efforts may help prepare Brazilian energy companies to enter the data center and cryptocurrency markets.

Despite the opportunities, challenges remain. Some areas with surplus energy also face droughts, raising concerns about water use. Infrastructure limitations and the lack of clear regulations for crypto mining in Brazil can make large projects difficult to implement. Companies negotiating big deals, such as 400 MW projects, have reported slow progress due to these hurdles.

Still, the potential is clear. By connecting renewable energy with cryptocurrency mining, Brazil can reduce energy waste, create new business opportunities, and strengthen its position in the global clean energy economy. For crypto miners, it is a chance to access cheap, abundant power, while for energy providers, it is a way to make the most of resources that would otherwise go unused.

Companies like Canaan Inc. (NASDAQ: CAN) could have business opportunities opening up in Latin America as crypto mining firms set up shop there and procure new mining equipment from these manufacturers.

Canaan Inc. (CAN), closed Tuesday's trading session at $1.27, off by 3.7879%, on 78,820,905 volume. The average volume for the last 3 months is 12,351,720 and the stock's 52-week low/high is $149.95/$299.9.

Circle Internet Group Inc. (CRCL)

Zacks, Schaeffer's, QualityStocks, MarketBeat, Greenbackers, MarketClub Analysis, Top Pros' Top Picks, Investor Spec Sheet, Investors Underground, The Night Owl, Early Bird, FutureMoneyTrends.com, Premium Stock Alerts, ShazamStocks, TheStockAdvisor, StreetAuthority Financial, Streetwise Reports, Wyatt Investment Research, The Stock Enthusiast, analystratings, AnotherWinningTrade, Bold Stocks, CrushTheStreet.com, Eagle Financial Publications, Earnings360, Vantage Wire, Trade of the Week, Insider Wealth Alert, InvestmentHouse, OTC Markets Group, Market FN, Stock Research Newsletter, The Street, Millennium-Traders, Oakshire News Bulletin, 360 Wall Street, StockReport, StockGuru, SmallCap Network, SmallCapVoice and The Trading Report reported earlier on Circle Internet Group Inc. (CRCL), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Russia is taking steps to create its own system for managing crypto transactions through government-backed infrastructure.

The initiative aims to tackle the current difficulties surrounding the use of digital assets. Reports from the Russian news outlet TASS suggest that the project will introduce a new legal framework, allowing broader use of crypto in areas that have not yet been explored.

Although the State Duma and the Bank of Russia have been working on developing national regulations for crypto, the country still doesn’t have a unified government-run platform that oversees digital transactions. Such infrastructure would allow multiple organizations to use cryptocurrencies more efficiently and securely.

Ivan Chebeskov, the country’s Deputy Finance Minister, noted that there is a growing need for a domestic system that supports every part of the crypto market, from mining to trading. While he did not provide many details about the structure or purpose of the new framework, Chebeskov noted that the project is being developed jointly with the Bank of Russia.

The upcoming infrastructure is expected to form part of a national exchange linking companies, miners, and investors that want to use cryptocurrencies for cross-border payments.

The Bank of Russia has already allowed select financial institutions to create crypto-based investment products for professional investors who can handle higher risks. Some major players include the Moscow Exchange and the country’s largest bank, Sber.

Russia’s efforts reflect a larger international trend. Several countries are experimenting with digital versions of their national currencies. For instance, China has introduced the digital yuan, and the European Union has been testing its own version, the digital euro.

Despite these developments, ordinary Russian citizens still face limited opportunities to invest in crypto. The government remains cautious about opening up the market fully to the public. Still, certain steps have been taken to broaden access for specific types of investors.

Earlier this year, the Bank of Russia approved the offering of crypto derivatives for wealthy investors with assets worth over 100 million rubles ($1.2 million) or an annual income above 50 million rubles ($608,141).

The Ministry of Finance has also proposed easing these requirements to allow more participants into the market. While the bank hasn’t yet approved the changes, it has hinted that by 2026, investment funds may be permitted to hold cryptocurrencies in their portfolios.

Currently, Russian digital wallets are estimated to hold around $25 billion worth of digital assets, showing that public interest in cryptocurrencies continues to grow despite government restrictions.

Financial tech firms like Circle Internet Group Inc. (NYSE: CRCL) with a focus on blockchain technology will be pleased that the Russian government is taking steps to create infrastructure that enables the deepening of the crypto industry’s utility in the country because such actions boost the reach of the entire industry.

Circle Internet Group Inc. (CRCL), closed Tuesday's trading session at $148.72, up 0.1414046%, on 12,330,816 volume. The average volume for the last 3 months is 212,143,639 and the stock's 52-week low/high is $0.09/$0.47.

Calidi Biotherapeutics Inc. (CLDI)

QualityStocks, InvestorBrandNetwork, MissionIR, SeriousTraders, SmallCapRelations, BioMedWire, SmallCapSociety, Tip.Us, StocksToBuyNow, NetworkNewsWire, TinyGems, Stocks to Buy Now, Tiny Gems, MarketClub Analysis, MarketBeat, Premium Stock Alerts and InsiderTrades reported earlier on Calidi Biotherapeutics Inc. (CLDI), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

While immunotherapy has scored a significant level of success in treating many types of cancer, it hasn’t registered similar efficacy in leukemia, especially acute myeloid leukemia, also known as AML. Researchers at Lund University, Sweden have found a possible reason why this could be so. 

The team sought to identify any unique surface proteins on leukemia cells that could be targeted with new forms of treatment, especially if those unique proteins didn’t exist on healthy cells. Thoas Fioretos, who led the research team, explains that they found one protein on the surface of leukemia stem cells and this particular protein wasn’t present on blood stem cells that were healthy. 

The protein was discovered after taking blood samples from a trio of patients suffering from highly intractable AML. The study team mapped the proteins on these stem cells and then compared them to the mapping of stem cells taken from healthy individuals. The comparison identified SLAMF6 as a protein only occurring on the surface of leukemia cells. 

To further validate their finding, the team obtained blood stem cell samples from 50 more AML patients and the same surface protein existed on the samples obtained. 

Using advanced function analysis tools, the researchers found that the surface protein was pivotal in aiding the cancer to evade a person’s immune system so that the disease keeps growing without any interference from the immune system. 

Using a custom antibody developed by the researchers, SLAMF6 was blocked from performing its evasive role and the immune system immediately started attacking the cancerous cells. Tests on the impact of blocking this surface protein were conducted in test tubes and on mice. Both cases showed immune system action against the cancer. 

Carl Sanden, a corresponding author of this study, says blocking SLAMF6 was akin to switching the immune system back on. The surface protein acts like an off-switch for T cells in the immune system, and blocking those proteins is akin to flipping the switch back on. 

The researchers say their finding could provide one possible explanation why immunotherapies have had limited success in treating patients with AML. They add that their finding marks a major step forward though more research needs to be undertaken before their approach can become available to patients diagnosed with this cancer type having limited treatment options. 

The study team plans to further develop their antibody and conduct clinical trials aimed at moving their discovery towards regulatory approval for use in treating patients. Other scientists at companies like Calidi Biotherapeutics Inc. (NYSE American: CLDI) are also exploring the use of oncolytic viruses as another approach to supercharging the immune system against different cancers. A time may come when treatment teams have a wide range of cutting-edge personalized treatment options to administer to their patients. 

Calidi Biotherapeutics Inc. (CLDI), closed Tuesday's trading session at $1.6, up 2.5641%, on 315,630 volume. The average volume for the last 3 months is 10,491,448 and the stock's 52-week low/high is $1.41/$46.68.

Aston Bay Holdings Ltd. (ATBHF)

QualityStocks, SmallCapRelations, SeriousTraders, MissionIR, MiningNewsWire, InvestorBrandNetwork, ESGWireNews, Stocks to Buy Now, Tip.us, StocksToBuyNow, SmallCapSociety, Rocks & Stocks, NetworkNewsWire, rocksandstocks and ESGWireNews Editor reported earlier on Aston Bay Holdings Ltd. (ATBHF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

This past week, BHP announced its plan to invest over $555.1 million dollars in its Olympic Dam project. The project is located in the province of South Australia, on the traditional lands of the Arabana, Dieri, and Kokatha people. This province has 3 underground mines in Carrapateena, Prominent Hill, and Olympic Dam. 

BHP also operates an exploration project at Oak Dam, which could become the province’s fourth mine in the future. Olympic Dam holds one of the biggest deposits of copper, gold and uranium in the world, making it a major operation for the firm. 

In its announcement, the mining firm explained that this project would enhance operational efficiency and enable future growth prospects within the copper industry in South Australia. Its latest investment is expected to generate around 200 construction roles, strengthening the country’s standing as a leading global producer of copper. 

The funds will be directed towards the completion of an underground access tunnel into a mine area in the south of these operations, allowing access to a new section of the copper resource. They will also facilitate the installation of a new oxygen plant, which is expected to increase smelting rates for copper concentrate to 85 tons per hour. This will, in turn, support increased ability to process the red metal. 

Oxygen plays a crucial role in the smelting process as it helps separate and eliminate the iron and sulfur impurities from copper. 

Additionally, BHP plans to install a new backfill system that’ll deliver paste fill through underground pipes to different areas of the mine. Furthermore, these funds will improve ore transfer efficiency and minimize transport distances, supported by an upgraded underground electric rail system and six new locomotives. 

BHP plans to expand the rail system on the project to over 6km, from its current 4.8km. These changes come as the major miner works towards doubling output from the project. Over the last 3 years, the Olympic Dam project has produced over 300,000 metric tons of copper every year. In the last financial year, total output from the project stood at 316,000 tons of copper. 

By the mid-2030s, BHP hopes to be producing 650,000 tons of copper annually from this project. As the biggest copper producer globally, the company plans to grow its red metal base to roughly 2.5 million tons annually, from its current 1.7 million tons. The company plans to reach a final investment decision on a smelter and refinery expansion at this operation by 2027. 

The prospects of future copper supplies look bright given that in other regions around the world, entities like Aston Bay Holdings Ltd. (TSX.V: BAY) (OTCQB: ATBHF) are also advancing their copper exploration projects and extraction could start in the years to come. 

Aston Bay Holdings Ltd. (ATBHF), closed Tuesday's trading session at $0.047, up 15.7635%, on 2,000 volume. The average volume for the last 3 months is 175,562 and the stock's 52-week low/high is $0.03095/$0.083.

SEGG Media (SEGG)

Tip.us, StocksToBuyNow, QualityStocks, The Online Investor, StocksTips and Premium Stock Alerts reported earlier on SEGG Media (SEGG), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

SEGG Media (NASDAQ: SEGG, LTRYW) , the global sports, entertainment, and gaming conglomerate, announced a highly successful opening weekend for the Super League Kerala streamed live on its Sports.com platform. The event featured three competitive matches drawing more than 517,000 digital viewers with an average watch time of 60 minutes, alongside strong stadium attendance led by Calicut FC’s 2-1 victory over Forca Kochi FC. Backed by sponsors Sports.com and Amul, with Sony handling linear broadcasts, the SLK launch marked a milestone in Sports.com’s expansion across India and MENA, reinforcing its strategy to drive fan engagement, sponsorship revenue, and global football streaming growth.

To view the full press release, visit https://ibn.fm/PyMmd

About SEGG Media Corporation

SEGG Media (Nasdaq: SEGG, LTRYW) is a global sports, entertainment and gaming group operating a portfolio of digital assets including Sports.com, Concerts.com and Lottery.com. Focused on immersive fan engagement, ethical gaming and AI-driven live experiences, SEGG Media is redefining how global audiences interact with the content they love.

SEGG Media (SEGG), closed Tuesday's trading session at $4.04, up 0.7481297%, on 62,757 volume. The average volume for the last 3 months is 322,930 and the stock's 52-week low/high is $2.202/$26.45.

Fathom Nickel (FNICF)

QualityStocks, InvestorBrandNetwork, SmallCapRelations, SeriousTraders, MissionIR, MiningNewsWire, Tiny Gems, Stocks to Buy Now, Tip.us, StocksToBuyNow, NetworkNewsWire, Rocks & Stocks, SmallCapSociety, AllPennyStocks, InvestorIntel, Investor News and rocksandstocks reported earlier on Fathom Nickel (FNICF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Fathom Nickel (CSE: FNI) (FSE: 6Q5) (OTCQB: FNICF) announced it has completed the final cash payment and share issuance required under the Gochager Lake Earn-In Agreement, granting the Company full ownership of the Gochager Lake Property in Saskatchewan, subject to a 2% NSR royalty. Since entering the agreement in 2022, Fathom has expanded the property from 4,696 to over 34,000 hectares, advanced its geological model, and extended the mineralized corridor to more than 1.4 kilometers. CEO Ian Fraser said the milestone marks significant progress toward establishing a district-scale nickel camp through continued science-driven exploration.

To view the full press release, visit: https://ibn.fm/WzDPd

About Fathom Nickel Inc.

Fathom is a junior exploration company focused on exploring for and developing world class nickel camps in the province of Saskatchewan.

Fathom Nickel (FNICF), closed Tuesday's trading session at $0.0221, up 22.0994%, on 123,070 volume. The average volume for the last 3 months is 1,179,957 and the stock's 52-week low/high is $0.01293/$0.04274.

BioAdaptives (BDPT)

QualityStocks, MarketClub Analysis, Greenbackers, TheMicrocapNews, Real Pennies and BioMedWire reported earlier on BioAdaptives (BDPT), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

BioAdaptives (OTCMKTS: BDPT) announced the commercial launch of MyndMed(TM), a next-generation dietary supplement designed to enhance memory, focus, and overall brain performance. Following extensive testing with highly positive user feedback, the company is scaling production and expanding distribution to meet anticipated high demand beginning in November. Formulated to support cognitive function across short-, mid-, and long-term pathways, MyndMed(TM) delivers what the company calls “Mental Armor for Modern Minds(TM)” through clinically studied ingredients that promote alertness, neuroplasticity, and cellular energy balance. Manufactured in the U.S. in cGMP-certified facilities and third-party tested for purity, MyndMed(TM) is available nationwide at www.MyndMed.com.

To view the full press release, visit https://ibn.fm/2isuA

About BioAdaptives, Inc.
BioAdaptives, Inc. develops and markets science-based natural health and wellness products for both humans and animals. Its formulations leverage cutting-edge research in stem cell biology, adaptogens, and regenerative nutrition. The company’s mission is to enhance the quality of life through innovation that works in harmony with the body’s natural processes.

For more information, please visit our website at www.bioadaptives.com .

BioAdaptives (BDPT), closed Tuesday's trading session at $0.06, up 27.6596%, on 170,792 volume. The average volume for the last 3 months is 309,999 and the stock's 52-week low/high is $0.005/$0.18.

The QualityStocks Company Corner

D-Wave Quantum Inc. (NYSE: QBTS)

The QualityStocks Daily Newsletter would like to spotlight D-Wave Quantum Inc. (NYSE: QBTS).

D-Wave Quantum Inc. (NYSE: QBTS) and North Wales Police (NWP) completed a joint proof-of-technology project using a hybrid-quantum application to optimize police vehicle placement, cutting response times by nearly 50% and reducing coordination planning from four months to four minutes. The test also demonstrated that NWP could respond to at least 90% of incidents within their target response time using the hybrid-quantum application. Following the successful project, the UK Office of the Chief Scientific Adviser for Policing recognized it to be of national cross-government departmental interest with opportunity for future development and deployment. The project highlights the importance and value of cross-border collaboration, with D-Wave TM technology—developed in Canada by a U.S. company—addressing a key UK public sector challenge.

To view the full press release, visit https://ibn.fm/u6CTs

At only 23 years old, Jacob Palmer has already built a successful career as an electrician and business owner. He started the company in 2024 after deciding college wasn't the right path for him. Looking back, he has no regrets about skipping higher education. "I'm really happy doing this because it's given me independence," he said. More young people are starting to make similar choices. Skilled trades such as electrical work, plumbing, welding, HVAC repair, and masonry are becoming more appealing, especially as college costs continue to rise. According to a Jobber report, about 57% of Gen Z respondents said they worry about student debt and see it as a major reason to skip college altogether. Similarly, 18-year-old Kayden Evans, a senior at Mountain View High School, plans to enter a hands-on trade after graduation. Currently interning at Empire Cat, a heavy equipment company, he hopes to become a field technician. "AI can't take apart an engine," he said. "That's something only people can do." As more tech innovations are brought to market by enterprises like D-Wave Quantum Inc. (NYSE: QBTS), the employment landscape is likely to be shaken up a lot more and the workforce will need to adapt to these changes. 

D-Wave Quantum Inc. (NYSE: QBTS) is a leader in quantum computing systems, software and services focused on delivering customer value via practical quantum applications for problems such as logistics, artificial intelligence, materials sciences, drug discovery, scheduling, fault detection and financial modeling. As the only provider building both annealing and gate-model quantum computers, the company is unlocking commercial use cases in optimization today, while building the technologies that will enable new solutions tomorrow.

D-Wave is a pioneer in quantum computing, with a history of delivering the world’s first commercial quantum computer; the first real-time quantum cloud service; countless hardware and software product and research milestones; and the planned first cross-platform quantum solution which will deliver both annealing and gate-model quantum computers to customers via an integrated platform. Its current commercial product offerings include: Advantage™ (fifth generation quantum computer), Leap™ (quantum cloud service), Launch™ (quantum computing onboarding service) and Ocean™ (full suite of open-source programming tools).

D-Wave’s relentless pursuit of practical quantum computing has resulted in the technology being used today by some of the world’s most advanced enterprises – more than 25 of the Forbes Global 2000 use D-Wave.

D-Wave’s commercial customers include blue-chip industry leaders like Volkswagen, Accenture, BBVA, NEC Corporation, Save-On-Foods, DENSO and Lockheed Martin. The company boasts an extensive IP portfolio featuring more than 200 issued U.S. patents and over 100 peer-reviewed papers published in leading scientific journals.

Founded in 1999, D-Wave is the world’s first commercial supplier of quantum computers. With headquarters and the Quantum Engineering Center of Excellence based near Vancouver, Canada, D-Wave’s U.S. operations are based in Palo Alto, California.

Advantage™ Quantum Computer

 

With the Advantage™ Quantum Computer, D-Wave has incorporated two decades of experience and over 10 years of customer feedback to create the first and only quantum computer designed for business. The platform features a new processor architecture with over 5,000 qubits and 15-way qubit connectivity. This is 2.5x more connections and more than double the number of qubits than the company’s previous generation quantum computer.

D-Wave’s quantum computers, first located in its facilities in British Columbia, have been available to North American users through its Leap™ quantum cloud service since 2018. It has since introduced new Advantage systems in Julich, Germany, and most recently, Marina Del Rey, California, which marked the availability of the first Advantage quantum computer physically located in the United States.

That new deployment is part of the USC-Lockheed Martin Quantum Computing Center (QCC) hosted at USC’s Information Sciences Institute (ISI), a unit of the University of Southern California’s prestigious Viterbi School of Engineering. Additionally, Amazon Web Services (AWS) and D-Wave announced that the U.S.-based system is available for use in Amazon 2racket, expanding the number to three different D-Wave quantum systems available to AWS users.

Leap Quantum Cloud Service

 

D-Wave’s customers interface with its systems through the Leap™ quantum cloud service. Leap delivers immediate, real-time access to the company’s Advantage quantum computer and quantum hybrid solver service, all with enterprise-class performance and scalability.

Leap allows developers proficient in Python to get started building and running quantum applications. Through a seamless and secure cloud-based connection, users can easily start solving complex problems of up to 1 million variables and 100,000 constraints.

Using Leap, D-Wave customers have developed quantum hybrid applications for use cases in manufacturing, logistics, financial services, life sciences, materials science, retail and transportation. By eliminating the need to wait hours, days or weeks to get good answers to a broad array of problems, D-Wave is helping businesses move forward.

D-Wave Launch

D-Wave Launch™ is the company’s onboarding platform aimed at helping businesses easily start their quantum journey. Through this program, D-Wave’s team of experts and partners aid enterprises in identifying best use cases for quantum and work with them to develop a proof of concept and production pilot.

From there, the team coordinates with customers to get their hybrid quantum applications up and running, providing ongoing Leap quantum cloud access to ensure the application is operating smoothly and delivering real business value.

Target Verticals

While the potential applications for quantum computing are effectively limitless, D-Wave has identified a number of industry verticals as key areas of focus for its quantum architecture, providing case studies for each. These include:

  • Manufacturing – D-Wave worked with Volkswagen to identify a commercial optimization application, the binary paint shop problem, which was run on D-Wave’s hybrid solver service. The solver outperformed four purely classical methods on problem sizes at commercial scale (N=3,000). In a separate project, similar inputs were tested using a leading ion trap system, which failed to find any commercial solution.
  • Life Sciences – Menten AI makes use of D-Wave quantum computing to assist in the design of novel therapeutic peptides—short strings of amino acids that can act as potent drugs. With the rise of COVID-19, D-Wave’s Advantage system made it possible to identify molecules that might be especially well-suited for binding and inhibiting the related spike protein, producing several promising peptide designs.
  • Finance – Multiverse Computing, a leader in developing quantum solutions for the financial sector, leveraged D-Wave’s hybrid solver service in a collaboration with BBVA, one of the world’s largest financial institutions. Multiverse demonstrated management strategies that far exceeded the granularity of traditional returns in a fraction of the time, helping BBVA identify a low-risk portfolio for investment.

Market Opportunity

The quantum computing total addressable market is projected to grow between $450 billion and $850 billion over the next 15 to 30 years, with between $5 billion and $10 billion of anticipated TAM growth coming in the next three to five years, according to Boston Consulting Group. Driving factors behind this growth include rising investments in quantum computing tech by governments and an increasing number of commercial use-cases.

Forward-thinking organizations see quantum as an opportunity to move ahead of the competition. From finding efficiencies and reducing waste to decreasing time to solution and solving problems abandoned due to complexity, the business value is real. According to data from 451 Research, 40% of large enterprises are already experimenting with quantum computing.

D-Wave is strategically positioned – in an industry with significant barriers to entry – as evident by a decades-long track record serving a roster of blue-chip customers. The company is singularly focused on helping its customers achieve clear value by leveraging quantum computing in practical business applications. With a full stack of systems, software, developer tools and services, D-Wave is working to enable enterprises, governments, developers and researchers to access the power of quantum computing, thereby providing an intriguing opportunity for prospective investors.

D-Wave’s current investor base includes PSP Investments, Goldman Sachs, BDC Capital, NEC Corporation, Aegis Group Partners and In-Q-Tel.

Leadership Team

Dr. Alan Baratz has served as the CEO of D-Wave since 2020. Previously, as Executive Vice President of R&D and Chief Product Officer, he drove the development, delivery, and support of all of D-Wave’s products, technologies, and applications. Dr. Baratz has over 25 years of experience in product development and bringing new products to market at leading technology companies and software startups. As the first president of JavaSoft at Sun Microsystems, he oversaw the growth and adoption of the Java platform from its infancy to a robust platform supporting mission-critical applications in nearly 80 percent of Fortune 1000 companies. He has also held executive positions at Symphony, Avaya, Cisco, and IBM. Dr. Baratz holds a doctorate in computer science from the Massachusetts Institute of Technology.

John Markovich is the company’s CFO. He brings to D-Wave over three decades of experience working with rapidly growing private and public technology companies across all stages of development. Mr. Markovich has directed the finance, accounting, tax, treasury, M&A, legal, operations, customer service, IR, HR, and IT functions for companies ranging from privately held pre-revenue startups to an NYSE-listed Fortune 500 multi-national company with over $1.2 billion in annual revenue. During his career, he has negotiated and closed over 150 debt, equity, M&A, and joint venture transactions exceeding $2.5 billion in value; over a dozen private placements; nearly a dozen M&A transactions; and several international joint ventures. Mr. Markovich holds a BS in Business from Miami University and an MBA from the Michigan State Graduate School of Business.

D-Wave Quantum Inc. (NYSE: QBTS), closed Tuesday's trading session at $35.72, up 1.9989%, on 90,346,459 volume. The average volume for the last 3 months is 59,457,464 and the stock's 52-week low/high is $0.8724/$37.8999.

Recent News

NRx Pharmaceuticals Inc. (NASDAQ: NRXP)

The QualityStocks Daily Newsletter would like to spotlight NRx Pharmaceuticals Inc. (NASDAQ: NRXP).

FDA grants NRx Pharmaceuticals approval of a Suitability Petition for single-patient preservative-free ketamine.

The decision enables re-filing of an Abbreviated New Drug Application ("ANDA") for the company's KETAFREE(TM) product, which the company has now done.

Current ketamine formulations use multidose vials with a toxic preservative, Benzethonium Chloride.

U.S. ketamine market is estimated at $750 million annually, presenting a significant commercial opportunity.

NRx is also advancing NRX-100 and NRX-101 for suicidal depression and PTSD, both with FDA designations.

The move aligns with U.S. policy goals on reshoring drug production and reducing toxic additives.

NRx Pharmaceuticals (NASDAQ: NRXP) , a clinical-stage biopharmaceutical company, announced it has received approval from the U.S. Food and Drug Administration ("FDA") for its Suitability Petition to advance KETAFREE(TM), a preservative-free version of ketamine ( https://ibn.fm/qFzsh ). The ruling allows the company to re-file its Abbreviated New Drug Application ("ANDA") for the product, which it has now done, a key step in bringing it to market ( https://ibn.fm/nogJi ).

NRx Pharmaceuticals Inc. (NASDAQ: NRXP) is a clinical-stage biopharmaceutical company focused on developing therapies for central nervous system disorders, with a particular emphasis on conditions characterized by acute suicidality. The company is leveraging its proprietary NMDA receptor modulation platform to address significant unmet medical needs in suicidal depression, bipolar depression, chronic pain, and post-traumatic stress disorder (PTSD).

With a commitment to advancing life-saving treatments, NRx is developing novel therapeutics aimed at providing safer and more effective alternatives to current treatment options. Its lead investigational drug, NRX-101, is positioned to be the first FDA-approved oral therapy for suicidal bipolar depression. Additionally, the company is working to bring NRX-100 (intravenous ketamine) to market as an approved treatment for acute suicidal depression, a condition for which existing treatments remain limited.

By integrating cutting-edge science with a patient-focused mission, NRx aims to transform the standard of care for individuals suffering from severe psychiatric and neurological conditions.

NRx has also established HOPE Therapeutics, a subsidiary focused on delivering interventional psychiatric care through a nationwide clinic network. HOPE Therapeutics aims to become the first coordinated system of care for suicidal depression and PTSD, combining ketamine, Transcranial Magnetic Stimulation (TMS), digital therapeutics, and other precision psychiatry tools in a supervised clinical environment.

NRx is headquartered in Wilmington, Delaware. HOPE is headquartered in Miami, Florida.

Product Portfolio

NRx Pharmaceuticals’ pipeline includes multiple late-stage therapeutic candidates targeting psychiatric and neurological disorders:

  • NRX-100: A preservative free intravenous ketamine formulation under development for acute suicidal depression, backed by strong clinical trial data and Fast Track designation from the FDA.
  • NRX-101: An oral therapy with a dual mechanism targeting NMDA and 5-HT2A receptors, designed for patients with suicidal treatment-resistant bipolar depression. The drug has received Breakthrough Therapy designation from the FDA.
  • Expanded Research: The company is further evaluating NRX-101 as a potential non-opioid treatment for chronic pain and a therapy for complicated urinary tract infections.

NRx’s therapeutic pipeline is designed to address conditions with limited or no treatment options, with the potential to improve patient outcomes and expand the standard of care.

HOPE Therapeutics

HOPE Therapeutics, a wholly owned subsidiary of NRx Pharmaceuticals, is establishing a national network of psychiatrist-led clinics focused on suicidal depression and PTSD. Its care model integrates preservative-free ketamine, TMS, digital therapeutics, and supervised psychiatric support to deliver rapid, measurable outcomes.

The company is targeting more than 30 clinic acquisitions by year-end 2025. Recent agreements include the acquisition of Dura Medical and a letter of intent with Neurospa TMS, strengthening HOPE’s foundation in interventional psychiatry. In April, HOPE also secured a term sheet for strategic investment from a global medical device manufacturer.

With ketamine sales already underway under a 503B license, HOPE projects $100 million in annual revenue and profitability by year-end 2025. Positioned as a standalone care delivery company, HOPE offers NRx a potential future spinout opportunity to unlock additional shareholder value.

Market Opportunity

The need for innovative treatments in mental health and pain management is substantial. Suicide is a leading cause of death in the United States, claiming nearly 50,000 lives each year, with over 12 million adults seriously considering suicide annually, according to the CDC.

Suicidal depression, a distinct and life-threatening condition, affects approximately 3.5 million Americans. Despite this prevalence, the only approved intervention remains electroconvulsive therapy (ECT), a treatment with significant side effects and limited access. NRx aims to address this urgent gap with NRX-100, a preservative-free intravenous ketamine formulation being developed as the first FDA-approved treatment specifically for suicidal depression.

Additionally, approximately 7 million Americans suffer from bipolar depression, a condition where nearly half of patients will attempt suicide during their lifetime and one in five may die by suicide. NRX-101, NRx’s oral drug candidate, targets this critical unmet need as a potential first-in-class therapy specifically for bipolar depression.

Beyond mood disorders, chronic pain affects over 50 million individuals in the U.S., and PTSD impacts more than 12 million people—conditions for which few non-opioid, fast-acting treatments are available. By addressing these high-risk, underserved populations, NRx Pharmaceuticals is positioned to enter multiple billion-dollar markets and reshape the standard of care for severe psychiatric and neurological illnesses.

Leadership Team

Jonathan C. Javitt, Founder, Chairman & Chief Executive Officer or NRx, and Co-CEO of HOPE, brings four decades of experience in pharmaceutical and medical device development. He has led blockbuster drug and device programs at major companies, including Allergan, Merck, and Novartis, and has served as an advisor to four U.S. presidential administrations.

Michael Abrams, Chief Financial Officer, has nearly 30 years of experience in finance, having served in executive roles, including CFO positions at Arch Therapeutics and FitLife Brands. His expertise spans investment banking, corporate finance, and business strategy.

Rick Panicucci, Chief Technology Officer, has more than 25 years of leadership in pharmaceutical manufacturing and process development. He has held key positions at Novartis, WuXi AppTec, and other major companies, leading multiple approved New Drug Applications.

Matthew Duffy, Chief Business Officer, NRx, Co-CEO of HOPE, has over 35 years of experience in biotechnology business development and investment banking. He has held leadership roles at Pfizer, MedImmune, and several financial institutions, specializing in corporate strategy and partnerships.

Investment Considerations
  • NRx Pharmaceuticals is advancing a pipeline of innovative therapies targeting significant unmet needs in central nervous system disorders.
  • The company’s lead candidate, NRX-101, has received FDA Breakthrough Therapy designation, expediting its development.
  • NRX-100 (preservative free IV ketamine) has been granted Fast Track designation by the FDA for acute suicidal depression a patent for this novel formulation has been filed with the US Patent and Trademark Office.
  • HOPE Therapeutics, NRx’s interventional psychiatry subsidiary, is targeting $100M in revenue by year-end 2025 through a national clinic network treating suicidal depression and PTSD.
  • The company’s experienced leadership team has a proven track record in pharmaceutical development and commercialization.
  • NRx is positioned to address large and growing markets with its novel depression treatments, non-opioid therapeutic solutions and directly help patients in HOPE clinics.

NRx Pharmaceuticals Inc. (NASDAQ: NRXP), closed Tuesday's trading session at $3.67, up 9.5522%, on 651,013 volume. The average volume for the last 3 months is 443,712 and the stock's 52-week low/high is $1.1/$6.01.

Recent News

Datavault AI Inc. (NASDAQ: DVLT)

The QualityStocks Daily Newsletter would like to spotlight Datavault AI Inc. (NASDAQ: DVLT).

Datavault AI (NASDAQ: DVLT) , a leader in AI-driven data visualization, valuation, and monetization, announced new partnerships with Cutting Edge Sports Management and FN Esports to integrate its technologies across sports and entertainment. The collaborations will power tokenized sponsorships, blockchain-based athlete selection, and VerifyU(R)-enabled credentialing for Dream Bowl XIV, set for Jan. 11, 2026, at AT&T Stadium in Arlington, Texas. The initiative marks a major step in Datavault's entry into the $600 billion sports and entertainment market, combining AI-driven fairness, fan engagement, and health and wellness innovation across collegiate football and global esports.

To view the full press release, visit https://ibn.fm/P4M14

Datavault AI Inc. (NASDAQ: DVLT) is a pioneering leader in immersive, wireless sound technology, providing cutting-edge audio solutions for intelligent devices and next-generation home entertainment systems. The company collaborates with top consumer electronics (CE) brands and manufacturers, including industry giants like Harman International (a division of Samsung), LG, Hisense, TCL, Bang & Olufsen, and Platin Audio. WiSA Technologies delivers exceptional wireless sound experiences for high-definition content, including movies, music, sports, gaming, and esports, thereby enhancing the overall consumer experience in home entertainment.

As a founding member of WiSA™ (the Wireless Speaker and Audio Association), WiSA Technologies plays a critical role in defining wireless audio interoperability standards, ensuring seamless integration across devices and platforms. The company actively works with leading consumer electronics companies, technology providers, retailers, and ecosystem partners to promote and market spatial audio technologies, underscoring its commitment to advancing the future of audio and making high-quality, immersive sound accessible to a broader audience.

Headquartered in Beaverton, Oregon, WiSA Technologies extends its global reach with sales teams strategically located in Taiwan, China, Japan, Korea, and California. This international presence allows the company to effectively serve a diverse customer base and maintain strong relationships with key partners worldwide. By continuously innovating and setting new benchmarks in wireless audio, WiSA Technologies is well-positioned to remain at the forefront of the evolving home entertainment landscape.

The WiSA Association

The WiSA® Association, a wholly owned subsidiary of WiSA Technologies, is dedicated to promoting and standardizing spatial audio solutions for home entertainment, ensuring that immersive audio experiences are accessible to everyone. In collaboration with leading consumer electronics companies, technology providers, retailers, and ecosystem partners, the association works to advance wireless audio technology across various devices, making high-quality sound an integral part of modern home entertainment systems. As a key player in the industry, WiSA LLC, also known as the Wireless Speaker and Audio Association, is instrumental in fostering the adoption and integration of cutting-edge audio technologies.

Recently, the WiSA Association significantly expanded its influence by executing licensing agreements with leading HDTV brands, covering 43% of the HDTV market that uses the Android operating system, the most widely used OS in the market. By focusing on Android-based HDTVs and collaborating with speaker manufacturers, WiSA is actively building an ecosystem of WiSA E-enabled speaker systems, mirroring the success of its earlier WiSA HT technology. This strategic initiative, combined with WiSA E’s compatibility with multiple HDTV SoC providers and support for spatial audio formats like Dolby Atmos FlexConnect, positions the association at the forefront of transforming home audio experiences, driving widespread adoption across the home entertainment landscape.

Market Opportunity

From an investment perspective, WiSA Technologies Inc. is strategically positioned to capitalize on the growing demand for wireless and immersive audio experiences as consumer preferences shift toward high-definition home entertainment systems. As streaming services, gaming, and smart home technologies continue to expand, the need for seamless, high-quality audio solutions is becoming increasingly critical. WiSA Technologies, with its innovative wireless sound technology and strong partnerships with leading consumer electronics brands, is well-placed to capture a significant share of this expanding market, particularly as more consumers seek to enhance their home entertainment experiences.

Moreover, the company’s focus on setting industry standards through the WiSA Association further solidifies its role as a key player in the evolving audio landscape. By driving the adoption of wireless audio interoperability standards, WiSA Technologies not only ensures broad compatibility across devices but also positions itself as a leader in the market, capable of influencing future trends and technologies. This proactive approach, combined with its established global presence and collaborations with top-tier brands, provides WiSA Technologies with a strong foundation for sustained growth, making it an attractive opportunity for investors looking to gain exposure to the burgeoning home entertainment and smart audio sectors.

Leadership Team

Brett Moyer is the Chief Executive Officer, President, and Chairman of WiSA Technologies, Inc., and a founding member of the company. He has served in these leadership roles since August 2010. Prior to this, Mr. Moyer was the president and CEO of Focus Enhancements, Inc., where he oversaw the development and marketing of proprietary video technology. He has a rich background in consumer electronics, having held key positions at Zenith Electronics Inc., including Vice President and General Manager of its Commercial Products Division. Mr. Moyer also serves on the board of directors of Alliant International University and has previously served on the boards of HotChalk, Inc., and NeoMagic Corporation. He holds a Bachelor of Arts in Economics from Beloit College and an MBA in Finance and Accounting from Thunderbird School of Global Management.

Gary Williams is the Chief Accounting Officer and Vice President of Finance at WiSA Technologies, Inc., roles he has held since September 2019 and the company’s founding in August 2010, respectively. He previously served as the company’s Chief Financial Officer and Secretary until 2019. Mr. Williams has extensive experience in finance, having served as CFO of Quantum3D, Inc., and in similar roles at Focus Enhancements Inc. and Videonics Inc. He began his career in public accounting with Coopers & Lybrand LLP. Mr. Williams is a certified public accountant (inactive) and holds a bachelor’s degree in business administration with an emphasis in accounting from San Diego State University.

Investment Considerations
  • WiSA Technologies is strategically positioned in the rapidly growing market for wireless and immersive audio solutions, with strong partnerships with leading consumer electronics brands like Samsung, LG, and Bang & Olufsen.
  • The company’s proprietary WiSA E technology is driving innovation in home entertainment, offering a scalable platform that supports advanced audio formats such as Dolby Atmos and DTS:X.
  • WiSA Technologies’ recent licensing agreements with major HDTV brands covering 43% of the Android OS market significantly expand its market reach and revenue potential.
  • Led by an experienced management team with deep industry knowledge, WiSA Technologies is well-equipped to capitalize on the increasing demand for high-quality, wireless audio experiences.
  • With a focus on setting industry standards through the WiSA Association, the company is positioned as a leader in the evolving audio technology landscape, providing a strong foundation for long-term growth.
Additional Resources

Datavault AI Inc. (NASDAQ: DVLT), closed Tuesday's trading session at $2.53, up 21.6346%, on 173,266,491 volume. The average volume for the last 3 months is 105,967,840 and the stock's 52-week low/high is $0.2512/$3.1.

Recent News

PowerBank Corporation (Cboe CA: SUNN) (FSE: GY2) (NASDAQ: SUUN)

The QualityStocks Daily Newsletter would like to spotlight PowerBank Corporation (Cboe CA: SUNN) (FSE: GY2) (NASDAQ: SUUN).

Intellistake Technologies Corporation recently announced PowerBank Corporation (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: 103) as an enterprise beta partner, to help with the company's continued development of the IntelliScope AI suite.

The partnership involves PowerBank providing long-term testing and feedback to help refine IntelliScope's first enterprise-facing AI agents.

The close technical relationship is important for both companies and gives PowerBank an inside track on the use of AI tools focused on the energy industry.

Disseminated on behalf of PowerBank Corporation

Recently, Intellistake Technologies Corporation, a tech company that develops AI software solutions, revealed a partnership with PowerBank (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: 103) , a premier developer and owner of renewable and clean energy projects ( https://ibn.fm/REgL8 ).

PowerBank (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: 103) , a North American energy infrastructure developer and asset owner, announced it has executed a lease agreement for its 6.9 MW DC NY-Crawford Rd ground-mount solar project in New York's Capital District. Expected to qualify for incentives under NYSERDA's NY-Sun Program, the project will deliver clean, cost-saving power to local residents through a community solar model. PowerBank is advancing interconnection and permitting steps while securing project financing, leveraging its track record of over 100 MW of completed solar projects and a 1 GW development pipeline to support New York's 6 GW solar capacity goal under the state's Climate Leadership and Community Protection Act.

To view the full press release, visit https://ibn.fm/RAVhE

Renewable energy is fundamentally reshaping global economics, with clean energy sectors accounting for 10% of worldwide GDP growth in 2023. China's renewable sector drove nearly one-fifth of the country's 5.2% economic expansion while the European Union saw roughly a third of its growth fueled by clean energy. The United States deployed $338 billion in renewable financing during 2025, supporting installation of 50 gigawatts of new capacity in 2024 including a record 49 gigawatts of solar power that pushed renewables to 24% of total electricity generation. State and local governments are setting independent targets regardless. California mandated 100% clean energy by 2045, while Texas leads the nation in wind power despite its oil industry reputation, demonstrating that the transition reflects economic advantages compelling enough to override federal policy reversals and partisan resistance. As the uptake of renewable energy ramps up around the world, companies like PowerBank Corporation (NASDAQ: SUUN) (Cboe CA: SUNN) (FRA: 103) are set to have an even larger market to serve as they expand their operations into newer markets outside their original regions of focus.

PowerBank Corporation (NASDAQ: SUUN) (CSE: SUNN) is a premier developer and owner of renewable and clean energy projects, specializing in distributed and community solar initiatives throughout Canada and the United States. The company is committed to advancing the transition to sustainable energy by offering end-to-end services that include project origination, financing structuring, engineering, procurement, construction, and long-term operations and maintenance. PowerBank focuses on delivering innovative energy solutions through solar photovoltaic systems, battery energy storage systems (BESS), and electric vehicle (EV) charging infrastructure.

With a vision to provide scalable and reliable clean energy solutions, PowerBank has established itself as a leader in the renewable energy market by cultivating partnerships with utilities, commercial and industrial entities, municipalities, and residential customers. Its vertically integrated business model allows for optimized efficiency, cost management, and returns across diverse markets in North America. This end-to-end approach ensures greater control over project quality, costs, and operational outcomes, strengthening its competitive position.

Driven by a mission to create a greener future, PowerBank manages a robust portfolio of projects, including more than 100 megawatts (MW) of developed capacity and a pipeline exceeding one gigawatt (GW). The company’s commitment to sustainability and innovation makes it a recognized player in the renewable energy sector.

PowerBank has offices in Toronto, Ontario and New York.

Projects

PowerBank boasts an impressive and diverse portfolio of renewable energy initiatives that underline its leadership in the clean energy space. In the U.S., the company has over 250 MW of solar projects under development, principally in New York, focusing on community solar farms and commercial and industrial installations. Notably, PowerBank is developing several community solar projects in upstate New York, which will deliver clean energy to local residents and small businesses. Community solar projects, which are a cornerstone of PowerBank’s portfolio, provide scalable solutions for renters, homeowners, and small businesses to access affordable renewable energy, driving localized energy independence and economic savings.

In Canada, PowerBank has been a significant participant in Ontario’s Feed-in-Tariff program, where it has secured contracts for close to 200 MW of capacity. Its current management includes 70 solar power projects, totaling 28.8 MW of operational solar assets. The company’s expertise extends to the development and ownership of battery energy storage systems and EV charging stations, further diversifying its portfolio.

The company’s vertically integrated approach spans the entire project lifecycle, from initial site acquisition and grid interconnection to long-term operation and maintenance services. This ensures seamless execution and high-quality outcomes, providing value to stakeholders and supporting the transition to a clean energy future.

Market Opportunity

PowerBank operates within a growing renewable energy market driven by global demand for sustainable power solutions. In North America, favorable policies such as the Inflation Reduction Act in the United States and Canada’s investments in green technologies provide a robust foundation for renewable energy adoption. Solar PV installations and battery energy storage systems are at the forefront of this expansion, addressing energy reliability and grid stability while reducing carbon emissions.

The North American solar PV market was valued at $25.02 billion in 2019 and is projected to reach $120.74 billion by 2027, growing at a compound annual growth rate (CAGR) of 21.7% from 2020 to 2027. Likewise, the global BESS market is expected to expand from $7.8 billion in 2024 to $25.6 billion by 2029, at a CAGR of 26.9%, as reported by MarketsandMarkets. These trends are driven by the increasing integration of renewable energy sources, the need for grid resilience, and declining technology costs.

PowerBank’s operations have it well-positioned to capitalize on these opportunities. With a development pipeline exceeding one gigawatt (GW), the company is focused on meeting growing demand in community and commercial solar sectors. Decentralized energy solutions, such as virtual net metering and behind-the-meter systems, further enhance PowerBank’s market potential by addressing the critical need for flexible, cost-effective, and sustainable energy infrastructure. By leveraging its vertically integrated model and diversified portfolio, PowerBank stands as a key player in driving the renewable energy transition.

Leadership Team

Dr. Richard Lu, MD, MSc., MHSc., MBA, serves as President and CEO of PowerBank, bringing over 25 years of global energy experience. His leadership has been instrumental in advancing the company’s strategic initiatives across North America, Europe, and Asia, with a focus on renewable energy development and operational excellence.

Sam Sun, MBA, is the Chief Financial Officer of PowerBank. A Chartered Professional Accountant with more than 15 years of expertise in corporate finance, Mr. Sun has overseen financial strategies and internal controls across the cleantech, manufacturing, and mining sectors in Canada, the U.S., and China.

Andrew van Doorn, PE, serves as Chief Operating Officer, with nearly three decades of experience in engineering and construction. Mr. van Doorn has successfully led projects totaling over 200 MW of solar capacity and is a former Chairman of the Canadian Solar Industries Association.

Tracy Zheng, MBA, Chief Development Officer, has over 25 years of experience in brand marketing, business development, and solar project operations. She has spearheaded sales initiatives, conducted feasibility studies, and negotiated key partnerships that drive PowerBank’s growth.

Matt Wayrynen, Executive Chairman and Director, has a background in resource company management, venture capital, and mergers and acquisitions. Under his leadership, Solar Flow-Through Funds, where Mr. Wayrynen acted as CEO, was acquired by PowerBank, enhancing its asset portfolio and growth prospects.


Forward Looking Statements

This report contains forward-looking statements and forward-looking information ‎within the meaning of Canadian securities legislation (collectively, “forward-looking ‎statements”) that relate to the Company’s current expectations and views of future events. ‎Any statements that express, or involve discussions as to, expectations, beliefs, plans, ‎objectives, assumptions or future events or performance (often, but not always, through the ‎use of words or phrases such as “will likely result”, “are expected to”, “expects”, “will ‎continue”, “is anticipated”, “anticipates”, “believes”, “estimated”, “intends”, “plans”, “forecast”, ‎‎”projection”, “strategy”, “objective” and “outlook”) are not historical facts and may be ‎forward-looking statements and may involve estimates, assumptions and uncertainties ‎which could cause actual results or outcomes to differ materially from those expressed in ‎such forward-looking statements. In particular and without limitation, this report ‎contains forward-looking statements pertaining to the Company’s expectations regarding its industry trends and overall market growth of the data center market; the Company’s expansion into the data center market, including its pursuit of opportunities as a developer, owner, and strategic partner in data center infrastructure; supporting the demand for high-performance, sustainable energy solutions within the sector; details of the company’s business plan including development of solar power projects, battery storage projects and EV charging projects; the completion of any contracts for, or construction of, any data center, solar power, battery storage or EV projects; the receipt of interconnection approval, permits and financing to be able to construct projects; the receipt of incentives for projects; and the size of the Company’s development pipeline. No assurance ‎can be given that these expectations will prove to be correct and such forward-looking ‎statements included in this report should not be unduly relied upon. These ‎statements speak only as of the date of this report.‎

Forward-looking statements are based on certain assumptions and analyses made by the Company in light of the experience and perception of historical trends, current conditions and expected future developments and other factors it believes are appropriate, and are subject to risks and uncertainties. In making the forward looking statements included in this report, the Company has made various material assumptions, including but not limited to: obtaining the necessary regulatory approvals; that regulatory requirements will be maintained; general business and economic conditions; the Company’s ability to successfully execute its plans and intentions; the availability of financing on reasonable terms; the Company’s ability to attract and retain skilled staff; market competition; the products and services offered by the Company’s competitors; that the Company’s current good relationships with its service providers and other third parties will be maintained; and government subsidies and funding for renewable energy will continue as currently contemplated. Although the Company believes that the assumptions underlying these statements are reasonable, they may prove to be incorrect, and the Company cannot assure that actual results will be consistent with these forward-looking statements. Given these risks, uncertainties and assumptions, investors should not place undue reliance on these forward-looking statements.

Whether actual results, performance or achievements will conform to the Company’s expectations and predictions is subject to a number of known and unknown risks, uncertainties, assumptions and other factors, including those listed under “Forward-‎Looking Statements” and “Risk ‎Factors” in the Company’s most recently completed Annual Information Form, and other public filings of the Company, which include: the Company may be adversely affected by volatile solar power market and industry conditions; the execution of the Company’s growth strategy depends upon the continued availability of third-party financing arrangements; the Company’s future success depends partly on its ability to expand the pipeline of its energy business in several key markets; governments may revise, reduce or eliminate incentives and policy support schemes for solar and battery storage power; general global economic conditions may have an adverse impact on our operating performance and results of operations; the Company’s project development and construction activities may not be successful; developing and operating solar projects exposes the Company to various risks; the Company faces a number of risks involving Power Purchase Agreements (“PPAs”) and project-level financing arrangements; any changes to the laws, regulations and policies that the Company is subject to may present technical, regulatory and economic barriers to the purchase and use of solar power; the markets in which the Company competes are highly competitive and evolving quickly; an anti-circumvention investigation could adversely affect the Company by potentially raising the prices of key supplies for the construction of solar power projects; foreign exchange rate fluctuations; a change in the Company’s effective tax rate can have a significant adverse impact on its business; seasonal variations in demand linked to construction cycles and weather conditions may influence the Company’s results of operations; the Company may be unable to generate sufficient cash flows or have access to external financing; the Company may incur substantial additional indebtedness in the future; the Company is subject to risks from supply chain issues; risks related to inflation; unexpected warranty expenses that may not be adequately covered by the Company’s insurance policies; if the Company is unable to attract and retain key personnel, it may not be able to compete effectively in the renewable energy market; there are a limited number of purchasers of utility-scale quantities of electricity; compliance with environmental laws and regulations can be expensive; corporate responsibility may adversely impose additional costs; the future impact of any resurgence of COVID-19 on the Company is unknown at this time; the Company has limited insurance coverage; the Company will be reliant on information technology systems and may be subject to damaging cyberattacks; the Company may become subject to litigation; there is no guarantee on how the Company will use its available funds; the Company will continue to sell securities for cash to fund operations, capital expansion, mergers and acquisitions that will dilute the current shareholders; and future dilution as a result of financings.

The Company undertakes no obligation to update or revise any ‎forward-looking statements, whether as a result of new information, future events or ‎otherwise, except as may be required by law. New factors emerge from time to time, and it ‎is not possible for the Company to predict all of them, or assess the impact of each such ‎factor or the extent to which any factor, or combination of factors, may cause results to ‎differ materially from those contained in any forward-looking statement. Any forward-‎looking statements contained in this report are expressly qualified in their entirety by ‎this cautionary statement.‎

PowerBank Corporation (NASDAQ: SUUN), closed Tuesday's trading session at $1.93, up 6.044%, on 370,028 volume. The average volume for the last 3 months is 260,352 and the stock's 52-week low/high is $1.23/$6.43.

Recent News

Soligenix Inc. (NASDAQ: SNGX)

The QualityStocks Daily Newsletter would like to spotlight Soligenix Inc. (NASDAQ: SNGX).

Soligenix (NASDAQ: SNGX) , a late-stage biopharmaceutical company developing treatments for rare diseases, announced that its Data Monitoring Committee has completed its first review of the confirmatory Phase 3 FLASH2 study of HyBryte(TM) (synthetic hypericin) in cutaneous T-cell lymphoma, concluding there are no safety concerns and that the therapy maintains an acceptable safety profile consistent with prior trials. Enrollment is progressing on schedule, with an update expected in Q4 2025 and a blinded interim efficacy analysis planned for 1H 2026. The FLASH2 trial builds on the Company's earlier statistically significant Phase 3 results and additional supportive studies demonstrating HyBryte's efficacy and tolerability as a potential first-line treatment option for early-stage CTCL.

To view the full press release, visit https://ibn.fm/o0Xgw

Soligenix Inc. (NASDAQ: SNGX) is a late-stage biopharmaceutical company focused on developing and commercializing treatments for rare diseases with high unmet medical needs. Operating through two key segments, the company’s Specialized BioTherapeutics division is dedicated to oncology and inflammation therapies, while its Public Health Solutions segment advances vaccines and therapeutics targeting biothreats and infectious diseases.

The company is actively advancing multiple late-stage clinical programs, including HyBryte™ (SGX301), a novel photodynamic therapy for cutaneous T-cell lymphoma (CTCL). Additional candidates in development target psoriasis (SGX302), oral mucositis (SGX942), and Behçet’s disease (SGX945), while its public health efforts focus on heat-stable vaccines for ricin poisoning (RiVax®), Ebola (SuVax™), and Marburg (MarVax™) viruses, that have been supported by non-dilutive government grants and contracts of approximately $60 million to date.

With a diversified pipeline, multiple orphan and fast-track designations, and collaborations with government agencies, Soligenix is uniquely positioned for potential regulatory approvals and commercialization.

The company is headquartered in Princeton, New Jersey.

Pipeline and Development Programs

Specialized BioTherapeutics

Soligenix’s Specialized BioTherapeutics division develops treatments for oncology and inflammatory diseases, focusing on conditions with few or no effective therapeutic options. HyBryte™ (synthetic hypericin) has completed a Phase 3 study for CTCL, demonstrating statistically significant efficacy, and a second confirmatory Phase 3 trial is actively enrolling patients to support potential regulatory submissions worldwide. If approved, it would be the first non-mutagenic photodynamic therapy for early-stage CTCL, addressing an unmet medical need. It has received orphan drug designations in the U.S. and Europe, as well as Fast Track designation in the U.S.

SGX302, a photodynamic therapy based on the same active ingredient as HyBryte™, is in clinical development for mild-to-moderate psoriasis, with positive Phase 1/2 proof-of-concept results, it is actively enrolling patients in a Phase 2a clinical trial.

SGX942, designed to reduce inflammation and tissue damage in oral mucositis associated with cancer treatment, is progressing as a potential first-in-class therapy.
SGX945, targeting aphthous ulcers in Behçet’s disease, is actively enrolling in a Phase 2a clinical trial and has received fast-track designation, highlighting the urgency of developing effective treatments for this rare inflammatory condition.

Public Health Solutions

The company’s Public Health Solutions segment focuses on medical countermeasures for biothreats and emerging infectious diseases, leveraging non-dilutive government funding to advance its programs. RiVax®, a ricin toxin vaccine, has demonstrated strong preclinical and early clinical results and may be eligible for government procurement under the Strategic National Stockpile initiative.

The company’s RiVax®, as well as its vaccine candidates for Ebola and Marburg viruses are based on its proprietary ThermoVax® technology, which stabilizes vaccines for long-term storage without refrigeration. This approach could be transformative in regions where maintaining cold-chain logistics is challenging.

The ongoing development of these vaccines is supported by funding from NIH, BARDA, and DTRA, with the potential for up to three priority review vouchers (PRVs) upon regulatory approval, to be used for future programs or sold. Notably, PRVs have previously sold for roughly $100 million.

Market Opportunity

Soligenix targets markets with significant commercial potential, focusing on rare diseases and biodefense applications. HyBryte™ addresses CTCL, a disease affecting over 68,000 patients across the U.S. and Europe, with a total market opportunity exceeding $250 million. SGX302, the company’s therapy for mild-to-moderate psoriasis, serves a much larger population, as over eight million people in the U.S. are affected by the condition, representing a global market opportunity exceeding $1 billion.

SGX942, developed for oral mucositis in head and neck cancer patients, is aimed at a market worth more than $500 million, while SGX945 for Behçet’s disease serves a niche segment valued at over $200 million worldwide.

In addition to its rare disease programs, Soligenix’s Public Health Solutions division has the potential to generate significant revenue through government procurement contracts. By focusing on both orphan drug markets and government-funded biodefense initiatives, Soligenix has positioned itself for sustained revenue growth through multiple high-value opportunities.

Leadership Team

Christopher J. Schaber, PhD, Chairman, President & CEO, brings to the company more than 35 years of experience in the biopharmaceutical industry. Before joining Soligenix, he held senior and operational leadership roles at Discovery Laboratories, Acute Therapeutics, Ohmeda Pharmaceuticals, The Liposome Company, and Wyeth Ayerst Laboratories. He has extensive expertise in drug development, regulatory affairs, and corporate strategy, positioning him to drive Soligenix’s growth and advancement toward commercialization.

Richard Straube, MD, Chief Medical Officer, has more than 35 years of experience in drug development and clinical research. Prior to joining Soligenix, he held key leadership roles at Stealth Peptides, INO Therapeutics, Ohmeda Pharmaceuticals, and Centocor. Throughout his career, he has played a crucial role in bringing innovative therapies to market, particularly in inflammatory diseases and immunology, making him a valuable asset in advancing Soligenix’s late-stage clinical programs.

Oreola Donini, PhD, Chief Scientific Officer, has more than 20 years of experience in pharmaceutical research and development, with expertise in immunology, inflammation, and rare diseases. Before joining Soligenix, she held leadership positions at Inimex Pharmaceuticals, ESSA Pharma, and Kinetek Pharmaceuticals, where she worked on novel drug discovery and translational medicine. Her experience in preclinical research and product development supports Soligenix’s continued innovation in biopharmaceuticals.

Jonathan Guarino, CPA, CGMA, Chief Financial Officer, has over 25 years of experience in corporate finance and strategic financial planning. Before joining Soligenix, he held financial leadership positions at Hepion Pharmaceuticals, Covance, BlackRock, and Barnes & Noble. His expertise in financial management, accounting, and capital markets plays a critical role in Soligenix’s financial strategy and operational efficiency.

Investment Considerations
  • Soligenix has multiple late-stage assets with orphan and fast-track designations, providing a clear regulatory pathway toward potential approvals.
  • The company’s pipeline has a total addressable market exceeding $2 billion, spanning rare diseases, inflammation, and biothreat applications.
  • Soligenix has benefited from significant non-dilutive government funding, which reduces operational expenses and financial risk while supporting its public health initiatives.
  • The company is well-positioned for multiple development and regulatory catalysts, and commercial milestones, with lead candidates in cutaneous T-cell lymphoma, psoriasis, oral mucositis, and Behçet’s disease.
  • Soligenix is led by an experienced management team with a strong track record of success.

Soligenix Inc. (NASDAQ: SNGX), closed Tuesday's trading session at $1.64, up 19.708%, on 18,903,545 volume. The average volume for the last 3 months is 2,243,159 and the stock's 52-week low/high is $1.09/$6.2299.

Recent News

Oragenics Inc. (NYSE American: OGEN)

The QualityStocks Daily Newsletter would like to spotlight Oragenics Inc. (NYSE American: OGEN).

Oragenics (NYSE American: OGEN) , a clinical-stage biotechnology company advancing brain-targeted therapies through proprietary intranasal delivery technology, announced a strategic collaboration with Receptor.AI to accelerate the development of new drug candidates for neurological conditions. The partnership will apply AI-based receptor modeling to optimize binding profiles for compounds acquired in 2023, supporting Oragenics' expansion beyond its lead candidate, ONP-002, in concussion. CEO Janet Huffman said the collaboration underscores the company's evolution into a diversified neurological therapeutics developer, combining artificial intelligence and precision delivery to streamline preclinical discovery and enhance capital efficiency.

To view the full press release, visit https://ibn.fm/Wo8YZ

Oragenics Inc. (NYSE American: OGEN) is a development-stage biotechnology company pioneering innovative solutions in pharmaceutical medications, with a focus on nasal delivery systems. The company addresses critical unmet medical needs in neurology and infectious diseases, with research centered on developing drug candidates for mild traumatic brain injuries, such as concussions, and rare neurodegenerative disorders like Niemann-Pick Disease Type C. These areas represent significant challenges within the medical community due to limited treatment options making Oragenics’ mission especially impactful.

A key differentiator for Oragenics is its proprietary powder formulation technology, which enhances the stability and efficacy of pharmaceutical compounds. Combined with an advanced intranasal delivery device, this technology allows for administration intracellularly to the central nervous system, potentially offering more effective and faster-acting treatments.

The company’s focus on intranasal delivery also enables more patient-friendly and non-invasive treatment options, a growing area of interest in modern therapeutics. Beyond neurology, Oragenics is also targeting infectious diseases, leveraging its unique platform to position itself as a leader in cutting-edge biopharmaceutical solutions.

ONP-002

Oragenics’ lead candidate, ONP-002, is an innovative intranasal treatment for concussions that offers significant logistical advantages, including stability across a wide temperature range, eliminating the need for cold storage. This makes it ideal for varied environments such as sports fields or military operations. The drug is administered via a breath-propelled delivery system that diffuses intracellularly and activates gene response elements leading to the production of proteins that reduce inflammation, oxidative stress, and swelling to quickly, safely, and effectively counteract the harmful effects of a concussion.

Oragenics recently completed the synthesis of the ONP-002 batch for a planned Phase II clinical trial, with testing demonstrating over 99% purity after three months of stability. With an estimated 69 million concussions globally each year, ONP-002 could represent a major advancement in rapid response acute concussion treatment, offering new hope for reducing long-term disabilities associated with these injuries.

Market Opportunity

Oragenics offers a strong investment opportunity due to its focus on addressing large unmet needs in the neurology market, particularly with ONP-002, which targets the broad growing demand for concussion treatments.

The company’s proprietary intranasal delivery technology also opens up broader applications beyond concussion treatment, presenting additional revenue opportunities. As Oragenics advances through clinical trials, positive results could boost its valuation and attract attention from pharmaceutical heavyweights, positioning it as a promising player in the biotech industry.

Leadership Team

J. Michael Redmond, President & Interim Principal Executive Officer, has over 35 years of commercial experience in the biotech and medical device industries. He has held pivotal roles at companies such as Abbott Laboratories and KMC Systems Inc., where he helped grow the company to over $50M in revenue before its acquisition by Elbit Systems. As VP of Sales and Marketing at Bioject Inc., he was instrumental in raising capital and expanding the company’s market cap from under $10M to over $400M. Most recently, Mr. Redmond served as CEO of Odyssey Health Inc.

Janet Huffman, Chief Financial Officer, brings extensive financial expertise from her role as CFO of TRxADE HEALTH Inc., a Nasdaq-listed health services IT company. She was a founding member and CFO of Banyan Pediatric Care Centers, later leading its merger with Assisted 4 Living Inc. (now Arboreta Healthcare Inc.), where she continued as CFO until 2022. Ms. Huffman has also held senior finance roles at Signature HomeNow, Infinity Homecare, and Family Home Health Services. She holds both a bachelor’s and a master’s degree in accounting from the University of South Florida.

Investment Considerations
  • Oragenics’ lead candidate, ONP-002, addresses a significant unmet medical need in concussion treatment with a stable, non-invasive delivery method that offers substantial market potential.
  • The company’s proprietary intranasal delivery technology opens opportunities for expansion into multiple high-demand sectors, including neurology and infectious diseases.
  • Oragenics’ ability to eliminate cold storage requirements for ONP-002 enhances its commercial viability in diverse and challenging environments, such as military operations and sports fields.
  • The biotechnology sector’s growing focus on patient-friendly, non-invasive treatments positions Oragenics favorably for future partnerships and acquisitions.
  • Positive Phase II clinical trial results for ONP-002 could significantly increase Oragenics’ market valuation and attract interest from larger pharmaceutical companies.
Additional Resources

Oragenics Inc. (NYSE American: OGEN), closed Tuesday's trading session at $1.37, up 5.3846%, on 1,942,190 volume. The average volume for the last 3 months is 215,810 and the stock's 52-week low/high is $1.01/$18.897.

Recent News

ESGold Corp. (CSE: ESAU) (OTCQB: ESAUF)

The QualityStocks Daily Newsletter would like to spotlight ESGold Corp. (CSE: ESAU) (OTCQB: ESAUF).

ESGold (CSE: ESAU) (OTCQB: ESAUF) announced its inclusion in a NetworkNewsWire editorial titled "When the Dollar Blinks, Real Assets Take Center Stage," which explores how a weakening U.S. dollar and record-high gold prices are driving renewed investor interest in real assets. With gold recently trading near $3,700 per ounce and silver reaching 14-year highs, the article highlights ESGold's strong positioning in this environment, citing its fully funded, permit-backed business plan and pathway to production in 2026 as offering near-term profit potential and significant leverage to the ongoing gold cycle.

To view the full press release, visit https://nnw.fm/Tgk4U

ESGold Corp. (CSE: ESAU) (OTCQB: ESAUF) is a fully permitted, pre-production resource company on a clear path to near-term gold and silver production. With established infrastructure in place and a significant gold-silver resource, the company is uniquely positioned to generate near-term cash flow while unlocking the full potential of its Montauban Gold-Silver Project in Quebec—one of the top mining jurisdictions in the world.

ESGold is building a foundation for long-term growth through a dual-track strategy: cash-flow generation from tailings reprocessing to fund district-scale exploration.

The Montauban site, which operated as a mine for over 80 years, is now undergoing its first-ever systematic exploration program to determine just how large the remaining deposit may be. Near-term cash flow from tailings reprocessing will be used to fund exploration, with the goal of increasing the resource base and uncovering new discoveries across the expansive land package.

ESGold is advancing a scalable and replicable clean extraction model that turns legacy mine sites into revenue generating assets while setting a new industry benchmark for sustainable resource recovery.

The recent completion of a C$3.4M financing has enabled ESGold to initiate the final construction phase of its mill circuit—moving the company decisively toward production of gold and silver in Q3 2025.

Montauban Gold-Silver Project: Production Imminent

Located approximately 80 kilometers west of Quebec City, the Montauban Project is a past-producing gold-silver mine with surface and underground mineralization and over 900,000 tonnes of historical tailings. ESGold has invested over C$15 million to date, building out roads, power access, and a 16,000 sq. ft. processing facility. The company recently completed a C$3.4M financing to begin final construction of the mill circuit.

The company is fully permitted to enter into production that is expected to commence in Q3 2025 with a capacity of 500 tonnes per day, scaling to 1,000 tpd. An updated Preliminary Economic Assessment (PEA) is currently underway to reflect all-time high gold prices and the anticipated upside from the near-surface resource.

Parallels Between Broken Hill & Montauban

Broken Hill, discovered in 1883 in Australia, became the world’s largest source of silver, lead, and zinc—producing over $100 billion worth of metals. What made it unique was that the richest mineral zones were hidden deep underground in a twisted, boomerang-like shape, and it took decades to fully understand just how large the deposit really was.

Geologists now believe ESGold’s Montauban Project in Quebec may share similar traits. Like Broken Hill, it contains high-grade silver, lead, and zinc, along with gold—and sits within the same type of geological system known to host large, high-value mineral deposits. The rock formations, mineral assemblages, and structural complexity all suggest that Montauban could be hiding much more than what’s been historically uncovered. Academic studies now support this possible geological parallel, pointing to further evidence suggesting Montauban was formed under similar conditions as Broken Hill.

Exploration Upside

With production on the horizon, ESGold is advancing a major exploration campaign. Montauban has never undergone systematic modern exploration.

The company is currently completing a large-scale Ambient Noise Tomography (ANT) survey—a powerful 3D imaging technology that will define the size, shape, and continuity of the mineralized system. ANT is already showing strong results, with imaging going beyond the original 400m depth target and now expected to exceed 800m. This cutting-edge technology has the potential to reveal the full extent of the anomaly for the first time in Montauban’s 110-year history.

Scalable, Replicable, Clean Mining

Montauban is also part of a broader vision. Across Canada and globally, there are hundreds of orphaned or legacy mine sites that remain unrehabilitated despite containing valuable residual metals in tailings. Quebec alone is home to more than 259 of these sites, highlighting the scale of the opportunity. ESGold is advancing a scalable and replicable clean extraction model that transforms legacy sites into productive assets while setting a new benchmark for sustainable resource recovery.

The company has also performed testing that utilizes Dundee Sustainable Technologies’ CLEVR Process™, a proprietary non-cyanide extraction method that achieved 90.9% gold recovery in lab testing. This clean processing approach remains a valuable and scalable asset supporting ESGold’s near-term production and exploration growth strategy.

As a complement to its core mining operations, ESGold is developing clean technology solutions through a joint venture with DMCMS Inc. This initiative includes a polymer division that manufactures environmentally friendly products such as road stabilizers, dust suppressants, and other industrial blends—expanding the company’s sustainable commercial footprint.

Market Opportunity

ESGold is operating in a unique and specialized segment of the mining industry—reprocessing and revitalizing legacy mine sites. The Montauban Project offers both near-term cash flow and long-term growth potential by converting tailings into revenue while systematically exploring for additional high-value mineral endowments. The company’s established infrastructure, full permitting, and reclamation approvals reduce development risk and enhance execution timelines.

The broader green mining market is projected to reach $15.92 billion by 2030, according to Grand View Research. This growth is being driven by increased demand for responsible extraction methods, ESG-aligned practices, and critical mineral security. With construction underway at its fully permitted Montauban site—and exploration advancing along a Broken Hill-type geological model—ESGold is well positioned to emerge as Canada’s next premier gold and silver producer.

Leadership Team

Paul Mastantuono, Chief Executive Officer and Director, graduated with distinction from the University of Ottawa with a bachelor’s degree in social science, concentrating in criminology. He has extensive experience in the construction and transportation industries and has worked as an independent business consultant for various companies, including DNA Precious Metals Inc.

Brad Kitchen, President and Director, brings over 35 years of experience in investment banking and senior corporate management, primarily with resource-based companies. He has a detailed knowledge of regulatory, security, and tax issues, cross-border financings, and market influences, which he has applied to address business challenges for issuers and investors. Mr. Kitchen was also CEO of Eagle Hill Exploration, the company that generated in only five years the first Bankable Feasibility Study on the Windfall Lake Gold Project that was recently sold by Osisko Mining to Gold Fields for US$1.6 billion.

Andre Gautier, Senior Geologist and Director, brings over 47 years of experience in the Mining Exploration field and has worked in over 35 countries. His work experience includes entities such as: SOQUEM, Falconbridge Ltd., Noramco and Cambior Inc. Mr. Gauthier was president of MaxyGold Corp. (China), INCA Pacific Resources Inc., Lara Exploration Ltd., and Gold Holding Ltd. Mr. Gauthier also served as a Director of Vena Resources Inc., MaxyGold Corp., Lara Exploration Ltd., Western Union Peru, and Gold Holding Ltd., and from March 2015 until 2018, he served as interim Managing Director and CEO of Gold Holding Ltd., headquartered in Dubai (UAE). He has a BSC in Geology Eng. and MSC from UQAC (Chicoutimi, Quebec) and is an active member and leader of many mining and professional organizations (Canada, Peru, UAE, and China).

Investment Considerations
  • Fully Permitted & Funded for Near-Term Production: Construction underway soon at Montauban with gold-silver production expected in Q3 2025.
  • Tailings-to-Cashflow Strategy: Near-term cash flow from processing historic tailings will fund exploration across the district-scale land package.
  • Replicable Clean Mining Model: Scalable approach to legacy mine redevelopment in Canada and globally.
  • Broken Hill Analogue: Geological and structural parallels suggest Montauban may host a larger, mineralized system at depth.
  • Modern 3D Imaging Tech: Cutting-edge ANT survey is producing subsurface imaging beyond 800m, uncovering the potential size of the deposit.

ESGold Corp. (OTCQB: ESAUF), closed Tuesday's trading session at $0.64385, up 4.1491%, on 577,846 volume. The average volume for the last 3 months is 313,100 and the stock's 52-week low/high is $0.03/$1.1.

Recent News

Massimo Group (NASDAQ: MAMO)

The QualityStocks Daily Newsletter would like to spotlight Massimo Group (NASDAQ: MAMO).

Massimo Group (NASDAQ: MAMO) , a leading manufacturer and distributor of powersports vehicles, announced the nationwide availability of its all-new Sentinel 570 HVAC UTV, the debut model in its premium Sentinel Series. Designed for year-round comfort and performance, the 500-class utility vehicle features a fully enclosed, climate-controlled cabin, touchscreen GPS display, on-demand 4WD, and independent suspension. CEO David Shan said the Sentinel 570 "delivers a complete package of power, comfort, and advanced technology," reinforcing the company's commitment to innovation across work and recreational applications. Additional Sentinel models, including the 770, 900, and 1500, are slated for 2026 release.

To view the full press release, visit https://ibn.fm/2NFUi

Massimo Group (NASDAQ: MAMO) is a prominent manufacturer and distributor specializing in powersports vehicles and recreational watercraft. Established in 2009, the company has built a reputation for delivering value-packed utility terrain vehicles (UTVs), all-terrain vehicles (ATVs), and on-road vehicles to both recreational enthusiasts and professionals in the agricultural sector. In 2020, Massimo expanded its offerings by launching Massimo Marine, dedicated to crafting high-quality watercraft with advanced designs and exceptional customer service.

Massimo Group is focused on sustainability. Its recent initiatives, including the introduction of the MVR Series of electric carts, highlight the company’s commitment to eco-friendly solutions that address growing consumer demand for sustainability in the powersports and marine industries.

The company’s manufacturing capabilities have also evolved significantly. Its expanded 376,000-square-foot facility in Garland, Texas, now features advanced automation, including a vehicle assembly robot line. This addition is expected to significantly enhanced production capacity and efficiency, enabling Massimo to scale its operations and better meet market demand.

Product Portfolio

Massimo Group’s product portfolio showcases its dedication to innovation and versatility. Its diverse lineup combines advanced features, sustainability, and value to meet the needs of a dynamic market.

  • Massimo Motor: This category includes a wide range of UTVs, ATVs, go-karts, and mini-bikes designed for both recreational and practical applications. Notable recent additions include the T-Boss 1000 UTV, which combines rugged performance with advanced features, and the GKD 350 All-Terrain Go-Kart, a versatile two-seater ideal for various terrains. The Buck 550-6 Crew, a six-seater UTV, further expands this lineup, providing comfort and utility for families and light-duty users at an accessible price point.
  • Massimo Marine: Specializing in pontoon and tritoon boats, this division emphasizes luxury and performance. A recent collaboration between Massimo and Vision Marine Technologies has introduced electric pontoon platforms, catering to consumers seeking eco-friendly watercraft for both commercial and recreational use.
  • Massimo Electric: Reflecting the company’s commitment to sustainability, Massimo Electric focuses on low-speed electric vehicles (LSVs) tailored for diverse applications. Recent launches include the MVR 2X Golf Cart and MVR Cargo Max Utility Cart, which deliver advanced features and versatility for recreational users and professionals in industries like farming and groundskeeping.

By combining practicality with cutting-edge design, Massimo Group seeks to set the standard in the powersports and marine industries.

Market Opportunity

The global ATV and UTV market is experiencing robust growth, with North America projected to reach approximately $9.18 billion in 2024 and expand at a compound annual growth rate (CAGR) of 7.8% to $13.37 billion by 2029, according to Mordor Intelligence. Likewise, the U.S. electric UTV and ATV powertrain market is rapidly expanding. It was valued at $2.46 billion in 2022 and is expected to grow at a CAGR of 10.2%, reaching $5.18 billion by 2030, as reported by Grand View Research.

The pontoon boat market complements this growth, driven by increased interest in leisure and marine tourism. The market size exceeded $7.9 billion in 2022 and is projected to grow at a CAGR of 8.3% through 2032, according to Global Market Insights. Massimo Marine’s introduction of electric pontoon platforms through its Vision Marine partnership is expected to position the company to effectively address this growing market segment.

With strategic partnerships and an expanding dealer network, Massimo believes it is poised to penetrate deeper into domestic and international markets. The company’s service coverage currently includes over 2,800 retail locations, 600 motor service centers, and 5,500 marine service centers, ensuring robust support and accessibility for customers. This extensive distribution network underpins Massimo’s ability to capture market share and drive sustained growth.

Leadership Team

David Shan, Founder, Chairman, and CEO, established Massimo Motor in 2009 and Massimo Marine in 2020. He has led the company through significant growth phases, including the development of diverse product lines and its public listing. Shan holds a bachelor’s degree in international trade from Qingdao Ocean University of China.

Dr. Yunhao Chen, CPA, serves as the company’s Chief Financial Officer, bringing extensive experience in capital markets, financial reporting, and corporate governance since her appointment in May 2023. She holds a Ph.D. in Accounting and an MBA in Finance from the University of Minnesota.

Michael Smith, Vice President, joined Massimo in 2019 and played a pivotal role in launching Massimo Marine. With a strong background in powersports retail and product innovation, he is dedicated to driving new product development. Smith studied International Business and Marketing at the University of California, San Diego.

Investment Considerations
  • Massimo Group operates within a large and growing total addressable market that’s projected to surpass $18 billion by 2026.
  • The company’s cost-competitive and feature-rich products, including all-electric offerings, provide a strong value proposition.
  • Recent automation initiatives at its Texas factory are expected to improve manufacturing efficiency by an estimated 50%.
  • During the first three quarters of 2024, revenue increased by 20.8% to $91.2 million compared to the same period in 2023, reflecting strong market demand and successful product launches.
  • Strategic partnerships, such as those with Vision Marine and Rural King, enhance Massimo’s market reach and growth opportunities.
  • Consistent innovation, as seen in the launches of the T-Boss 1000 and MVR Series, is expected to drive Massimo’s push to be a leader in its industry.

Massimo Group (NASDAQ: MAMO), closed Tuesday's trading session at $2.93, even for the day, on 5,094 volume. The average volume for the last 3 months is 67,177 and the stock's 52-week low/high is $1.839/$4.6599.

Recent News

LaFleur Minerals Inc. (CSE: LFLR) (OTCQB: LFLRF)

The QualityStocks Daily Newsletter would like to spotlight LaFleur Minerals Inc. (CSE: LFLR) (OTCQB: LFLRF).

LaFleur Minerals is ramping up expectations for its gold exploration and processing operation in Quebec, working to restart its wholly-owned mill while completing an assessment of hole-drilling work across its 18,304-hectare (45,230-acre) project

The company's Swanson Gold Deposit site is part of the Abitibi Greenstone Belt, which is a globally renowned gold district

LaFleur anticipates its Beacon Gold Mill will deliver near-term revenues from processing custom raw ore projects for neighboring gold claims, while also being available for production of its own gold product once exploration gets fully under way

The company has drilled 24 holes to date on its gold deposit project and has reported enthusiasm for initial near-surface assays that demonstrate strong potential for expanding shallow, open-pit mineral resources at the site

In addition, LaFleur Minerals has announced listing on Tradegate, bolstering its international visibility and exposure to European markets

Gold exploration and development company LaFleur Minerals (CSE: LFLR) (OTCQB: LFLRF) expects to wrap up a comprehensive Preliminary Economic Assessment ("PEA") for its drilling project in the Abitibi Greenstone Belt of Quebec, Canada by the end of October, moving its gold exploration forward even as the company prepares to restart production at its gold mill operation for near-term revenues.

LaFleur Minerals Inc. (CSE: LFLR) (OTCQB: LFLRF) is a Canadian exploration and development company advancing the district-scale Swanson Gold Project in Québec’s prolific Abitibi Gold Belt and progressing toward the near-term restart of gold production at its wholly owned Beacon Gold Mill. The company’s strategy centers on consolidating strategic land packages—highlighted by its flagship Swanson Gold Project, a 160 km² district-scale property that includes several prospects rich in gold and critical metals previously held by Monarch Mining, Abcourt Mines, and Globex Mining. The company is leveraging its 100%-owned, fully permitted and recently refurbished Beacon Gold Mill to transition from explorer to near-term gold producer—a key inflection point that typically triggers a market re-rating, further bolstered by current rising gold market prices. By processing material from Swanson and offering custom milling to regional projects, LaFleur aims to generate cash flow with minimal capital outlay, targeting annual gold production of up to 15,000 to 20,000 ounces by early 2026.

LaFleur’s vision is to evolve into an intermediate gold producer by capitalizing on strong market conditions and Québec’s rich mining infrastructure. The location, in the world-class Abitibi Gold Belt, and its infrastructure advantage, positions LaFleur for regional consolidation, strategic partnerships, or acquisition interest. Its mission emphasizes efficient value creation through methodical exploration, low-cost asset advancement, and opportunistic acquisitions—including land and deposits from Monarch Mining, Abcourt Mines, and Globex Mining.

Québec ranks among the world’s top mining jurisdictions, offering access to flow-through capital and regulatory stability. LaFleur’s integrated strategy—combining exploration at Swanson, a permitted mill at Beacon, and potential custom milling agreements—supports a streamlined path to near-term production.

LaFleur Minerals is headquartered in Vancouver, British Columbia.

Projects

LaFleur Minerals’ operations focus on two strategically located assets in the Abitibi Gold Belt: the Swanson Gold Project and the Beacon Gold Mill and Mine. These projects leverage the region’s world-class mining infrastructure and high-grade gold potential to drive the company’s transition to production.

Swanson Gold Project

The Swanson Gold Project spans 16,600 hectares and hosts the Swanson, Bartec, and Jolin gold deposits along a major structural break in the Abitibi Gold Belt. The 2024 Mineral Resource Estimate for the Swanson deposit outlines 123,400 oz of gold in Indicated category (2.1 million tonnes at 1.8 g/t) and 64,500 oz in Inferred category (872,000 tonnes at 2.3 g/t). Located 66 km north of Val-d’Or, the Project is accessible by road and rail and benefits from more than 36,000 meters of historical drilling, along with existing infrastructure including an 80-meter decline portal.

Recent work—including airborne magnetics, soil sampling, and Induced Polarization surveys—has identified multiple high-priority targets and resulted in several high-grade gold assay results, including a grab sample grading 11.71 g/t Au at Jolin, which points to significant upside as the Company prepares to test multiple new zones.

LaFleur has defined over 50 drill targets at Swanson and nearby prospects (Bartec, Jolin, Marimac) and is completing a minimum 5,000-metre diamond drilling beginning in June 2025. LaFleur Minerals has also initiated permitting for a 100,000-tonne surface bulk sample averaging 1.89 g/t Au, which it plans to process at the Beacon Gold Mill as part of a near-term production strategy.

Beacon Gold Mill

LaFleur’s 100%-owned Beacon Gold Mill is a fully refurbished and permitted mill and tailings storage facility capable of processing 750 tonnes per day (tpd), with potential expansion to 1,800 tpd, with access to numerous nearby gold deposits that could be prime sources of ore. Located only 60 km from Swanson, it underwent a $20 million upgrade by Monarch Mining in 2022 and has been under care and maintenance since early 2023. LaFleur is finalizing a C$5-6 million restart plan, ramping up production by late 2025 into early 2026, processing Swanson mineralized material and assessing custom milling opportunities for regional deposits, creating multiple potential revenue streams.

The Beacon Gold Mill is a de-risked, proven asset that benefits from existing infrastructure, including access to roads, power, and skilled labor, and further enhances the overall value proposition of LaFleur by providing a clear path to production and potential revenue-generation.

Market Opportunity

LaFleur Minerals is targeting the gold mining and processing market in Québec’s Abitibi Gold Belt, one of the world’s most productive gold regions. Its fully permitted Beacon Gold Mill, with a 750 tpd capacity and authorization to process 1.8 million tonnes of tailings, is strategically positioned to handle material from LaFleur’s Swanson Gold Project and to offer custom milling for nearby deposits such as Granada Gold. The company projects annual production of over 30,000 ounces of gold once in full production, with potential for significant revenue generation based on prevailing market prices.

Global demand for gold remains robust, driven by geopolitical risk, inflation hedging, and central bank accumulation. The World Gold Council forecasts 3-5% annual demand growth through 2030, with average prices expected between $3,200 and $3,500/oz. Within this environment, Québec’s top-tier mining jurisdiction—ranked fifth globally by the Fraser Institute in 2023—offers streamlined permitting and access to flow-through capital. LaFleur’s low-cost Beacon restart (C$5-6 million) and proximity to more than 100 active and historical mines position the company to fill a growing need for small-to-medium scale custom milling.

At Swanson, LaFleur plans to grow its current 187,900-ounce resource toward 1 million ounces through its 2025 drilling program. This hub-and-spoke strategy, leveraging centralized milling and strong local infrastructure, reduces development risk and strengthens LaFleur’s foothold in one of the most attractive gold belts in the world.

Leadership Team

Kal Malhi, Chairman, is a successful entrepreneur and the Founder of Bullrun Capital Inc., where he has raised over $300 million for early-stage companies across the mining, oil and gas, biomedical, agriculture, and technology sectors. He specializes in advancing academic research into commercial ventures and public listings, with more than two decades of capital markets and leadership experience.

Paul Ténière, M.Sc., P.Geo., Chief Executive Officer, is a seasoned mining executive and Professional Geologist with over 25 years of global experience in the development of precious and base metals, critical minerals, and metallurgical coal projects. Mr. Ténière is an expert in NI 43-101 and S-K 1300 disclosure standards and has held senior roles including President & CEO, SVP Exploration, and Director with several publicly traded mining companies. Mr. Ténière also worked at the Toronto Stock Exchange (TSX) and TSX Venture Exchange as a mining expert and Senior Listings Manager listing dozens of mining companies and ensuring listed issuers met their corporate governance and compliance and disclosure requirements.

Harry Nijjar, Chief Financial Officer and Corporate Secretary, serves as Managing Director at Malaspina Consultants Inc., providing CFO and strategic financial advisory services to companies across multiple industries. He holds a CPA CMA designation from the Chartered Professional Accountants of British Columbia and a Bachelor of Commerce from the University of British Columbia.

Louis Martin, P.Geo., Technical Advisor and Exploration Manager, is a veteran geologist with more than 40 years of exploration experience. He has played key roles in significant gold and base metal discoveries, including the Louvicourt (1989) and West Ansil (2005) deposits—both recognized by the Association de l’Exploration Minière du Québec (AEMQ). He previously served as VP Exploration at Clifton Star Resources, where he led the pre-feasibility study for the 4.5 million-ounce Duparquet Gold Project. He is a registered geologist in Québec and Ontario.

Tara Asfour, Corporate Communications, Investor Relations and Strategy, is an experienced executive consultant with over 12 years of management, investor relations, communications and marketing experience, specialized in capital markets. In her previous positions, Ms. Asfour has led over US$550 million worth of fundraising and strategic development initiatives. Ms. Asfour holds a Master’s degree in Business Management, a Financial Markets Certificate from Yale University, and a Certificate in Alternative Investments from HBS. Previous positions include investor relations executive at Red Pine Exploration, Fancamp Exploration, Communications Director at Dominion Water Reserves (now Prime Drink Group Corp) and advisor to various other publicly listed firms in the resource and technology sectors. Ms. Asfour holds the Institute for Governance (IGOPP) Certification in Governance, Ethics in Business Environment and Corruption Prevention.

Peter Espig, Strategic Advisor and Consultant, has served as Vice-President at Goldman Sachs Japan in both the Principal Finance and Securitization Group and the Asia Special Situations Group, where his team participated in more than $10 billion in structured deals, capital raises, and cross-border transactions. Prior to Goldman Sachs, he was Vice-President at Olympus Capital, a New York-based private equity firm, where he focused on corporate restructurings, investment analysis, and international financing negotiations. He also played a pioneering role in some of the earliest SPAC transactions, totaling over US$1.2 billion, and brings deep experience in disciplined capital deployment and turnaround execution. Since 2013, Mr. Espig has served as President and CEO of Nicola Mining Inc. and is a board member of ESGold Corp and First Lithium Minerals. Mr. Espig holds a Bachelor of Arts from the University of British Columbia and an MBA from Columbia Business School, where he was a Chazen International Scholar. He has served on various public boards and was recognized among Industry Era’s “Top 10 Admired Leaders” in 2023.

Jean Lafleur, Senior Technical Advisor, is a Professional Geologist (Québec) with 45 years of experience in Canada and internationally including USA, Mexico, Latin America, Ireland, Spain and Africa. Earlier in his career he worked with Newmont, Falconbridge, Dome Mines, and Placer Dome and has been a C-suite executive for a number of junior exploration companies. Jean has remained active as a technical, management, and financing consultant with junior explorers since the early 2000’s through his own geological consultancy firm and throughout his career has led a number of teams in the discovery of precious and base metals, nickel, PGE’s, uranium, and iron deposits. Jean’s expertise includes mining company and project evaluations, audits, technical reporting, exploration program planning and execution, and research and development with a strong focus on Québec. Jean currently acts as a Senior Consultant, North America for Appian Capital Advisory LLP, a mining-focused private equity firm based in London, UK where through his extensive professional network he sources and presents potential mining transactions in North America to the Appian team for investment opportunities.

Investment Considerations
  • LaFleur Minerals’ fully permitted Beacon Gold Mill, acquired in 2024 and refurbished by its previous owner, offers a low-cost path to production with an estimated restart budget of C$5-6 million.
  • The Swanson Gold Project’s 2024 mineral resource estimate of 123,400 oz indicated and 64,500 oz inferred, alongside a 5,000-meter drilling program, supports the company’s goal of growing the resource toward 1 million ounces.
  • Consolidation of 15,290 hectares, including acquisitions from Monarch Mining, Abcourt Mines, and Globex Mining, has positioned LaFleur as a formidable exploration company in the Abitibi Gold Belt.
  • LaFleur’s hub-and-spoke development model, centered on its Beacon Mill, supports custom milling opportunities and enhances value from regional partnerships.
  • A highly experienced leadership team with over 100 years of combined expertise across mining, finance, and capital markets underpins the company’s transition from exploration to production.

LaFleur Minerals Inc. (OTCQB: LFLRF), closed Tuesday's trading session at $0.4606, off by 1.5181%, on 49,108 volume. The average volume for the last 3 months is 339,840 and the stock's 52-week low/high is $0.0139/$1.65.

Recent News

Forward Industries Inc. (NASDAQ: FORD)

The QualityStocks Daily Newsletter would like to spotlight Forward Industries Inc. (NASDAQ: FORD).

Forward Industries (NASDAQ: FORD) , a leading Solana treasury company, announced the launch of its institutional-grade validator node on the Solana blockchain, powered by DoubleZero's high-performance global network for distributed systems. Developed in collaboration with Galaxy and leveraging Jump Crypto's Firedancer client, the validator operates at 0% commission, allowing users to stake at no cost while supporting Forward's transition from capital provider to active ecosystem contributor. Chairman Kyle Samani said the initiative aligns Forward with blockchain infrastructure leaders and strengthens Solana's scalability and institutional readiness, marking a key milestone in the company's evolution within decentralized finance.

To view the full press release, visit https://ibn.fm/SNzXM

Forward Industries Inc. (NASDAQ: FORD) is building and managing a large-scale Solana (SOL) treasury, backed by some of the most influential investors in the digital asset space. The company’s strategy centers on long-term shareholder value through active participation in the Solana ecosystem, which it views as uniquely positioned to underpin future global capital markets due to its high throughput, deep economic activity, and growing developer adoption.

Through this shift, Forward Industries aims to create value by accumulating SOL and strategically deploying assets through on-chain opportunities including staking, lending, and participation in decentralized finance (DeFi). Forward also became the first U.S.-listed company to bring its common stock onto the Solana blockchain, reinforcing its focus on digital-native capital markets.

Forward Industries is headquartered in New York.

Solana Treasury Operations

In September 2025, Forward Industries closed a $1.65 billion private investment in public equity (PIPE) led by Multicoin Capital, Galaxy Digital, and Jump Crypto. The PIPE proceeds were deployed to acquire over 6.8 million SOL at an average price of $232 per token, with a portion executed on-chain via DFlow, a decentralized exchange aggregator built exclusively for Solana trading applications. The company has since staked the entirety of its treasury, actively generating yield through native Solana infrastructure and DeFi applications.

Forward’s strategy is centered on growing SOL per share, leveraging a range of tools including at-the-market (ATM) equity offerings and potential preferred equity issuance. The company is also targeting acquisitions and strategic partnerships within the Solana ecosystem to accelerate treasury yield and ecosystem alignment. As part of its infrastructure expansion, Forward tokenized its FORD shares on the Solana blockchain in collaboration with Superstate and plans to acquire an equity interest in the platform. The tokenized shares are expected to enable 24/7 trading, real-time settlement, and eligibility for use as DeFi collateral.

This shift was supported by the company’s board and executive team, whose composition reflects deep alignment with the Solana ecosystem — including leadership from Multicoin Capital and board observers from Galaxy and Jump Crypto. The company’s stated objective is to establish itself as the leading institutional participant in the Solana ecosystem, uniquely positioned to capture both economic yield and strategic exposure to one of the fastest-growing blockchain networks in the world.

Market Opportunity

Solana has emerged as the most performant blockchain in the digital asset space, processing over 8.9 billion transactions in Q2 2025 and sustaining approximately $3 billion in daily decentralized exchange (DEX) trading volume. Year to date, Solana applications have generated over $4 billion in fees and more than $1 billion in real economic value (REV), a proxy for free cash flow generated by the network.

DeFi participation, stablecoin usage, and developer activity have all grown substantially, with over $1.5 trillion in swap volume recorded through 2025. SOL staking yields have averaged over 8%, comprised of both inflationary rewards and organic yield from network activity. With 17 pending ETF applications and major institutions like BlackRock, Visa, PayPal, and HSBC integrating Solana, Forward Industries is positioned to benefit from a rising tide of institutional adoption, tokenization of real-world assets, and increased demand for high-performance blockchain infrastructure.

Leadership Team

Kyle Samani, Chairman of Forward Industries, is the co-founder and Managing Partner of Multicoin Capital, an early Solana backer and one of the largest holders of SOL. Samani contributed $25 million to the PIPE and is a key strategic leader behind Forward’s treasury roadmap.

Mike Pruitt, Interim CEO of Forward Industries, joined the board in February 2025 and was appointed Interim CEO in May. He is the founder of Avenel Financial Group and previously served as CEO of Chanticleer Holdings, bringing decades of public company leadership and capital markets experience.

Kathleen Weisberg, Chief Financial Officer of Forward Industries, was appointed CFO in July 2023 after serving as Corporate Controller since 2020. Weisberg is a CPA with prior roles at WW International, Symbol Technologies, and Ernst & Young.

Investment Considerations
  • Forward Industries is the largest publicly traded Solana treasury platform with more than 6.8 million SOL acquired to date.
  • The company raised $1.65 billion in a PIPE led by Multicoin Capital, Galaxy Digital, and Jump Crypto to fund its Solana treasury acquisition.
  • Forward generates yield through active staking, lending, and DeFi participation, increasing SOL-per-share over time.
  • The company tokenized its common stock on the Solana blockchain and plans to acquire an equity stake in Superstate to expand on-chain capital markets access.
  • Forward is led by crypto-native investors with deep strategic alignment in the Solana ecosystem.

Forward Industries Inc. (NASDAQ: FORD), closed Tuesday's trading session at $23.65, off by 6.9996%, on 489,344 volume. The average volume for the last 3 months is 615,458 and the stock's 52-week low/high is $3.3009/$46.

Recent News

HeartBeam Inc. (NASDAQ: BEAT)

The QualityStocks Daily Newsletter would like to spotlight HeartBeam Inc. (NASDAQ: BEAT).

HeartBeam is developing a portable, credit-card-sized device and proprietary software capable of capturing heart signals in three non-coplanar dimensions and reconstructing those signals into a full synthesized 12-lead ECG.

The importance of such innovation is underscored by the widespread impact of heart disease, such as heart rhythm problems.

The VALID-ECG study results carry significant weight for both clinical adoption and HeartBeam's commercialization pathway.

Early and accurate detection of heart rhythm problems can mean the difference between life-saving intervention and a missed opportunity, which is why new advances in cardiac diagnostics carry such weight. HeartBeam (NASDAQ: BEAT) has reported promising results from its pivotal VALID-ECG study ( https://ibn.fm/BDiIa ), demonstrating that its synthesized 12-lead ECG technology delivers a strong correlation with the clinical gold standard of traditional 12-lead ECGs for non-life-threatening arrhythmias.

HeartBeam Inc. (NASDAQ: BEAT) is a medical technology company pioneering a new approach to cardiac care by delivering hospital-grade electrocardiogram (ECG) insights outside traditional clinical settings. Its proprietary platform supports a scalable app-based solution for real-time heart monitoring.

The company’s mission is to empower both patients and physicians with actionable cardiac data wherever symptoms begin, addressing a critical gap in the first hours of cardiac events. Through its connected cardiac care ecosystem, HeartBeam is establishing a new model for remote monitoring that deepens patient engagement and delivers more actionable insights for physicians. This approach is designed to obtain early diagnosis which could reduce time to treatment, improve outcomes, and lower costs across the healthcare continuum.

HeartBeam’s system aims to bring clinical-grade cardiac assessment into the home. HeartBeam is preparing for commercial launch as its 12-lead ECG synthesis software undergoes regulatory review, building on prior clearance of its 3D ECG system for arrhythmia assessment. The company plans to leverage its unique longitudinal ECG dataset and deep learning algorithms to advance predictive capabilities in the future.

HeartBeam is headquartered in Santa Clara, California.

Products

HeartBeam’s flagship innovation is its credit card-sized, cable-free ECG device that collects heart signals in three non-coplanar dimensions and synthesizes a 12-lead ECG. Cleared by the FDA in December 2024 for arrhythmia assessment, the HeartBeam System enables patients to capture high-fidelity heart data during symptomatic episodes, even outside a clinical environment.

The company’s pending 12-lead ECG synthesis software, developed from the same 3D signal acquisition, successfully met clinical endpoints in the VALID-ECG study and is currently under FDA review for arrhythmia assessment. This software combined with an on-demand cardiologist reader service is expected to form the backbone of HeartBeam’s commercial launch strategy, providing patients with access to a synthesized 12-lead ECG outside of the traditional hospital setting and enabling physician interpretation of patient ECGs from anywhere.

From the core, the team is building an ecosystem that includes integration with wearables, automated arrhythmia assessments, AI-driven wellness features, community features and trending insights. The ecosystem is intended to drive adoption and increase the overall value of the HeartBeam System.

Artificial Intelligence and Predictive Analytics

To enhance its diagnostic capabilities, HeartBeam is developing AI-powered arrhythmia detection algorithms to be validated in collaboration with Mount Sinai Heart. In early testing, these deep learning algorithms achieved diagnostic accuracy comparable to standard 12-lead ECGs when classifying atrial fibrillation, atrial flutter, and sinus rhythm.

Additionally, HeartBeam’s AI engine has the potential to transform routine monitoring into predictive power in the future. The company’s platform enables frequent readings, building a unique longitudinal ECG dataset unique that no one else offers. By leveraging deep learning on the repeated measurements, there is an opportunity to develop predictive capabilities, such as screening for hidden cardiac conditions and forecasting risk of future events. The unique longitudinal dataset will create a defensible data moat as the company continues to advance its AI program.

Market Opportunity

HeartBeam is targeting a large unmet need in cardiac care by delivering hospital-grade ECG diagnostics to patients outside of traditional healthcare settings. Cardiovascular disease is the leading cause of death worldwide, yet most cardiac events occur at home, where standard 12-lead ECGs are not available, leading to costly delays in diagnosis and treatment. HeartBeam’s FDA-cleared 3D ECG technology is designed to close this critical gap with on-demand, remote diagnostic capabilities.

The company’s initial commercialization strategy focuses on two distinct U.S. entry markets. The first includes approximately 500,000 elevated-risk patients in concierge care settings, representing a $250 million to $500 million annual revenue opportunity. The second addresses a larger direct-pay segment of 2.6 million elevated-risk individuals, with potential revenues of $1.3 billion to $2.6 billion annually. Future expansion may include reimbursement-driven pathways through Medicare Advantage, providers, and payer partnerships.

HeartBeam anticipates annual subscription pricing between $500 and $1,000 per patient, with roughly 50% gross margins on device costs and 70%+ on recurring revenue. Based on a model using five U.S. regions, each with an estimated 75,000 eligible patients, HeartBeam projects that just 10% adoption would generate approximately $20 million in gross profit—enough to reach cash flow break-even under current pricing and margin assumptions. Over time, the company’s longitudinal ECG dataset and predictive AI capabilities are expected to deliver additional value to healthcare systems, research institutions, and life science partners.

Leadership Team

Robert Eno, Chief Executive Officer and Director, brings over 30 years of experience in the medical technology industry, including leadership roles at HeartFlow, OptiMedica, and NeoGuide Systems. He joined HeartBeam as President in January 2023 and was appointed CEO in October 2024, later joining the board in May 2025 to support commercial growth.

Branislav Vajdic, Ph.D., Founder and Chief Technology Officer, is a semiconductor and medtech innovator who previously led product design teams at Intel and founded NewCardio. He holds over 20 patents and is the original architect of HeartBeam’s core technology.

Tim Cruickshank, Chief Financial Officer, oversees financial strategy and capital allocation. He works closely with the leadership team to support commercialization while maintaining financial discipline aligned with key regulatory milestones.

Peter Fitzgerald, M.D., Ph.D., Chief Medical Advisor, is Director of the Center for Cardiovascular Technology at Stanford and a seasoned clinical trialist with over 175 studies and 650 publications. He has founded over 20 medtech companies and advises the FDA on digital health analytics.

Ken Persen, Chief Technology Officer, has more than 28 years of experience in cardiac rhythm management and digital health. He previously served as CTO and CEO at LIVMOR and held engineering roles at Cameron Health and Guidant.

Investment Considerations
  • HeartBeam has developed and secured FDA clearance for a credit card-sized 3D ECG device that enables arrhythmia assessment outside of traditional clinical settings.
  • The company’s 12-lead ECG synthesis software successfully met pivotal study endpoints and is currently under FDA review, supporting near-term commercialization.
  • HeartBeam’s AI algorithms, validated in collaboration with Mount Sinai, demonstrated high diagnostic accuracy and provide a foundation for predictive cardiac monitoring. The company plans to submit its AI algorithms for FDA clearance in the future.
  • The company holds more than 20 issued patents, including protections for device design and risk-based diagnostic algorithms.
  • HeartBeam was honored with the 2025 Innovation Award in Remote Cardiac Diagnostics, reinforcing its leadership position in the digital health space.

HeartBeam Inc. (NASDAQ: BEAT), closed Tuesday's trading session at $1.76, off by 5.3763%, on 122,703 volume. The average volume for the last 3 months is 98,026 and the stock's 52-week low/high is $0.9101/$3.48.

Recent News

Bollinger Innovations, Inc. (NASDAQ: BINI)

The QualityStocks Daily Newsletter would like to spotlight Bollinger Innovations, Inc. (NASDAQ: BINI).

British battery electric vehicle sales surged nearly one-third in September compared to the previous year, reaching 72,800 units. The record figures followed the UK government's July reintroduction of electric car grants worth up to £3,750 ($5,035), responding to intense carmaker lobbying about struggles meeting mandatory zero-emission vehicle targets. The Society of Motor Manufacturers and Traders reported the surge as reinstated government subsidies attracted buyers during the market's most critical sales month. The subsidy program applies to roughly one-quarter of battery electric vehicles sold in Britain, including models from Citroën, Renault, Nissan, and Vauxhall. The limited subsidy pool combined with September's strong sales could exhaust available funding faster than government projections anticipated, potentially leaving later buyers without financial assistance as the market adjusts to operating under challenging zero-emission vehicle requirements. UK manufacturers of electric vehicles are enjoying the sales boost provided by the reintroduced government incentives while their counterparts in the U.S., such as Bollinger Innovations, Inc. (NASDAQ: BINI), are having to go back to the drawing board to see what more they can do to attract buyers in the wake of the federal government suddenly ending the EV incentives in the country. 

Bollinger Innovations, Inc. (NASDAQ: BINI) is a Southern California-based automotive company building the next generation of commercial electric vehicles (“EVs”) with United States-based manufacturing located in Tunica, Mississippi.

In August 2023, Mullen began commercial vehicle production in Tunica. As of January 2024, both the Mullen ONE, a Class 1 EV cargo van, and Mullen THREE, a Class 3 EV cab chassis truck, are California Air Resource Board (“CARB”) and EPA certified and available for sale in the U.S. The Company’s commercial dealer network consists of Papé Kenworth, Pritchard EV, National Auto Fleet Group, Ziegler Truck Group, Range Truck Group, Eco Auto, and Randy Marion Auto Group, providing sales and service coverage in key West Coast, Midwest, Pacific Northwest, New England, and Mid-Atlantic markets.

In September 2022, Bollinger Motors, of Oak Park, Michigan, became a majority-owned EV truck company of Mullen Automotive. Bollinger Motors has passed numerous milestones including its B4, Class 4 electric truck production launch on Sept. 16, 2024, and the development of a world-class dealer network with over 50 locations across the United States for sales and service support.

Mullen Commercial

Mullen is defining a new era in commercial vehicles with its connected and customized solutions aimed at making businesses more efficient and profitable.

Mullen ONE Class 1 EV Cargo Van

The Mullen ONE class 1 commercial electric vehicle is the first of its kind in the U.S. market. This van was designed to navigate within narrow urban streets and residential roads, all while maximizing payload and cargo space. The Mullen ONE’s height is less than 6.5 feet, meaning your driver can park the vehicle in a residential garage.

Mullen THREE Class 3 Electric Truck

The efficient urban utility low cab forward features a tight turning diameter of 38 feet and excellent visibility for superior maneuverability on narrow city streets. Even in reverse, maneuverability is a breeze with our standard backup camera and 7-inch display screen. This versatile chassis provides a clean top-of-rail for easy upfitting with bodies up to 14 feet long and over 5,300 lbs of payload. In addition, the design of the LCF chassis allows more cargo length within a given overall length.

Mullen Commercial EVs are eligible for several federal and state level EV incentives, which can be combined for maximized savings.

Mullen ONE:

  • $7,500 Federal Tax Credit
  • $3,500 MOR-EV Incentive (Massachusetts only)
  • $7,500 ComEd Business & Public Sector EV Rebate Program (Illinois only)

Mullen THREE:

  • $7,500 Federal Tax Credit
  • $45,000 California’s Hybrid and Zero-Emission Truck and Bus Voucher Incentive Project (HVIP) (California only)
  • $15,000 MOR-EV Incentive (Massachusetts only)
  • $30,000 ComEd Business & Public Sector EV Rebate Program (Illinois only)

In the last two years, Mullen has conducted over 100 vehicle demos or pilots across various industries in the U.S. resulting in significant progress, including new sales opportunities and vehicle orders received and or completed:

  • Universities: Princeton University, University of Virginia (UVA), University of California, Los Angeles (UCLA)
  • Local city governments: Cities of Dublin, Ohio, Raleigh, North Carolina, Los Angeles, California, Seattle, Washington and Orange County, North Carolina
  • Small businesses: From local florist shops to health care providers delivering supplies

Mullen has an extensive dealer network in the U.S. with renowned dealers nationwide including:

  • Papé Group (California, Oregon, Washington)
  • National Auto Fleet Group (California)
  • Pritchard EV (Iowa)
  • Eco Auto (Massachusetts)
  • Ziegler Truck Group (Minnesota)
  • Range Truck Group (Washington)
  • Mullen Commercial Vehicle Center (California)

Mullen Commercial EVs are available for purchase on Sourcewell under NAFG’s Sourcewell Contract # 091521-NAF which offers Class 1-3 light duty trucks, cars, vans, SUVs, cab chassis, and electric vehicles with related equipment and accessories to U.S. government agencies.

Bollinger Motors

Mullen entered the medium-duty truck classes through its September 2022 acquisition of a controlling interest in EV truck innovator Bollinger Motors. The acquisition gave Mullen access to a significant pipeline of interest from large companies for commercial electric truck classes 3-6 in a wide range of markets, such as last-mile delivery, refrigeration, utilities and upfitters.

The 2025 Bollinger B4 chassis cab is an all-new, all-electric Class 4 commercial truck designed from the ground up with extensive fleet and upfitter input. Bollinger’s unique chassis design protects the 158-kWh battery pack and components to offer unparalleled capability and safety in the commercial market. The vehicle also features a payload in excess of 7,300 pounds with an average driving range of 185 miles. Bollinger Motors began serial production of the B4 on Sept. 16 via its manufacturing partnership with Roush Industries at their facility in Livonia, Michigan.

Bollinger Motors has passed numerous milestones in recent months, including:

  • 30 B4s delivered and paid for, worth nearly $4.5 million, since start of production
  • Its production launch on Sept. 16 at Roush Industries in Livonia, Michigan
  • Achieving FMVSS compliance
  • Receiving the Certificate of Conformity from the Environmental Protection Agency, and CARB certification
  • The creation of a world-class dealer and service network
  • An agreement with Our Next Energy in Novi, Michigan, for battery packs
  • Providing a full warranty coverage of the B4 chassis cab
  • Announcing Syncron as its warranty administration partner and Amerit Fleet Solutions as its mobile service provider
  • A partnership with EO to power EV charging infrastructure, equipment and technology solutions for Bollinger’s dealers and customers

Bollinger Motors has qualified for multiple federal and state incentive programs, including:

  • Inflation Reduction Act incentives of up to $40,000 per vehicle
  • California: Innovative Small e-Fleet (ISEF) Pilot Program, with incentives up to $120,000 per vehicle
  • Massachusetts: voucher of up to $30,000 per vehicle from Massachusetts Offers Rebates for Electric Vehicles (MOR-EV)
  • New York: up to $100,000 from NYTVIP through NYSERDA
  • Pennsylvania: up to a $20,000 grant from Alternative Fuels Incentive Grant Program (AFIG) of the Pennsylvania Department of Environmental Protection

Mullen FIVE RS

The Mullen FIVE RS is an ultra-high-performance EV Crossover featuring a top speed of over 200 mph and acceleration from 0-60 mph in under 2 seconds. The FIVE RS is equipped with 800-volt architecture, all-wheel drive, two-speed gearbox, and over 1,100 horsepower.

The Mullen FIVE RS is planned for launch in Germany with vehicle sales planned for December 2025. Initial vehicle market territories include the EU in 2025, followed by the UAE and South Africa in early 2026.

Mullen is partnering with Faissner Petermeier Fahrzeugtechnik AG (“FPF”), which has decades of experience in the development and production of serial components and sophisticated vehicles for global brands such as Piech Automotive, Gumpert Automotive and is in partnership with BMW of all the above. FPF is certified according to the IATF standard and fulfills all the special requirements of the Federal Motor Transport Authority in Germany.

EV Market Outlook

The global EV market was reported to consist of 3,269,671 units in 2019, a figure that is expected to grow at a CAGR of 21.1% through 2030 to a total of 26,951,318 units worldwide. This market’s monetary value was estimated at $162.34 billion in 2019 and is expected to grow at a CAGR of 22.6%, resulting in an approximate value of $802.81 billion by 2027. The primary driver for this exponential growth is a worldwide increase in vehicle emissions regulations.

Management Team

Mullen is led by an executive team with extensive EV, OEM and high-growth startup experience.

David Michery is the CEO and Founder of Mullen and has been leading the company and its divisions since inception in 2014. With over 25 years of executive management, marketing, distressed assets, and business restructuring experience, Mr. Michery brings a wealth of relevant knowledge and expertise to the Mullen brand. He has notably created 12 trademarks so far to develop the company brand and vision.

Mr. Michery is working towards a sustainable future by creating a suite of clean-energy, electric vehicles at varied price points. With entirely US based manufacturing and operations, Mr. Michery is also determined to have Mullen Technologies play a role in shaping a self-sustaining local economy by creating more jobs in America.

Mr. Michery manages risks and company expectations as a pathway to success and has personally overseen several businesses that totaled over $1 billion in transactions. His key strength is the ability to be fiscally responsible and lead teams to complete projects on time and within budget. As a seasoned professional in this space, Mr. Michery has demonstrated skill in building businesses from the ground up and into successful entities that subsequently sold for hundreds of millions of dollars.

Investment Considerations
  • Mullen Automotive is working diligently to provide exciting commercial EV options assembled in the United States and made to fit perfectly into the American commercial operations
  • Mullen Automotive owns its U.S. manufacturing and assembly facility in Tunica, MS (commercial vehicles)
  • In September 2022, Bollinger Motors, Inc. became a majority-owned EV truck company of Mullen. Bollinger has passed numerous milestones, including its B4, Class 4 electric truck production launch on Sept. 16, 2024, and the development of a world-class dealer and service network with over 50 locations across the United States
  • Mullen currently has three commercial EVs in the market including the Mullen ONE Class 1 EV cargo van, the Mullen THREE Class 3 electric truck, and the Bollinger B4 Class 4 electric truck
  • The Mullen FIVE RS, an ultra-high-performance FIVE RS EV Crossover features a top speed of over 200 mph and acceleration from 0-60 mph in under 2 seconds, is gearing up for launch in Germany in December 2025
  • Mullen is working to actively develop the next-generation solid-state polymer (SSP) batteries and to transition to American-made battery components
  • The global EV market is forecast to grow at a CAGR of 22.6% through 2027.
  • Mullen is led by CEO and Founder David Michery, a seasoned executive with more than 25 years of management, marketing, distressed assets and business restructuring experience

Bollinger Innovations, Inc. (NASDAQ: BINI), closed Tuesday's trading session at $1.23, off by 12.1429%, on 3,009,344 volume. The average volume for the last 3 months is 1,445,538 and the stock's 52-week low/high is $1.15/$138000000000.

Recent News

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPRMissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.